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ABSTRACT 

Illness Perceptions of Hemodialysis (HD) Patients with Type 2 
Diabetes Mellitus (OM) and their Association with Empowerment 
Pula, J.L.; St. Joseph's Regional Medical Center & Seton Hall University 
INTRODUCTION: According to the U.S. Renal Data System, DM was the 
primary cause of ESRD for 54% of all new patients in 2007. Hemodialysis 
patients with Type 2 DM are faced with many treatment challenges, which may 
lead to a negative perception of illness and a decrease in empowerment. The 
Common Sense Model (CSM) based on Leventhal's Self-Regulation Model 
provides a theoretical framework for the concept of illness perceptions in relation 
to coping behaviours and measurable outcomes such as well-being, quality of life 
(QoL), and self-management. The purposes of this study were: 1) to examine if 
there is an association between illness perceptions and perceptions of 
empowerment in HD patients with Type 2 DM; and 2) to investigate what 
differences in illness perceptions and perceptions of empowerment exist between 
HD patients with Type 2 OM and non-dialysis patients with Type 2 DM. 
METHODS: This was a prospective, cohort-nested, case-control study. A total 
of 101 participants {51 HD patients with Type 2 DM (Group 1; case) and 50 non­
dialysis patients with Type 2 DM (Group 2; control)} signed an IRS approved 
written informed consent and authorization form prior to screening. Participants 
were asked to offer responses regarding their illness perceptions, empowerment, 
and sociodemographic information, which took approximately 45 minutes, one­
time during their regularly scheduled HD treatment or family medicine clinic visit. 
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The measures included the Diabetes Empowerment Scale - Short Form (DES­
SF), Brief Illness Perception Questionnaire (Brief-IPQ), and General Information 
Form (GIF). Calculations were performed using GraphPad Prism (Version 5.0) 
and SPSS (Version 18.0) on a personal computer platform for data analysis. 
Differences between sociodemographic characteristics, Brief-IPQ scores and 
DES-SF scores between the two groups were compared by use of non­
parametric tests. In addition, multivariate analyses were used to adjust for 
potential confounders amongst the baseline characteristics. 
RESULTS: Univariate analyses indicated differences between 3 characteristics 
of the Brief-IPQ. First, the non-dialysis group perceived illness affects their lives 
more severely (consequences; P = 0.005). Secondly, the dialysis group 
perceived illness will more likely last forever (time/ine; P =0.040). However, via 
multivariate analyses, the PI discovered male dialysis patients, 56 years of age 
or older, are particularly affected. Lastly, the non-dialysis groups perception of 
emotion affecting their lives is greater (emotional representation; P = 0.0002), 
which turned out to be insensitive to any of the 3 potential confounders (age, 
gender, and years of schooling, respectively). 
CONCLUSIONS: Findings from this study may positively impact educational 
threads by bringing attention to the need for nephrology healthcare providers to 
identify HD patients' (with Type 2 DM) illness perceptions and their association 
with perceptions of empowerment. By modifying illness perceptions 
impairments, empowerment can, therefore, be indirectly addressed. Educational 
interventions for this patient population may then be designed {based on the 
- 2 ­
CSM and Empowerment Theory), specifically for identification and coping 
strategies, ultimately increasing QoL. 

Keywords: end stage renal disease, dialysis, diabetes, hemodialysis, illness 

perceptions, empowerment, self-regulation model, common sense model, 

quality of life 
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Chapter 1 

INTRODUCTION 

Background of the Problem 
Diabetes mellitus (DM) is a chronic illness caused by an error in 
carbohydrate metabolism that affects over 16 million individuals in the U.S. The 
chronic nature of DM presents considerable physiological and psychological 
concerns. This dissertation study explored illness perceptions in hemodialysis 
(HD) patients' withType 2 DM and whether there is an association with 
perceptions of empowerment. 
Dialysis patients with Type 2 DM are faced with demanding treatments 
and need to have empowerment when taking care of their health and treatments 
(Rantanen, et. aI., 2008). 
Patients with Type 2 DM must monitor their blood sugars regularly and 
adhere to meal planning and scheduled appointments. They may experience 
loss of sensation; therefore, need to observe foot care practices. Psychological 
stressors include loss of self-concept and self-esteem. 
According to the U.S. Renal Data System, as of December 31.2007, 
nearly 111,000 people living in the U.S. have end stage renal disease (ESRD), 
the final stage of kidney disease. Of those ESRD patients, 44% (48,871) also 
have DM (either Type 1 or Type 2) (USRDS, 2009). 
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In 2007, the calculated rate of new ESRD cases was 354 per million 
patient population. Diabetes mellitus was the primary cause of ESRD for 54 
percent of all new patients in 2007 (USRDS, 2009). The overall adjusted rate of 
ESRD due to OM was 155 million per population in 2007; 36 percent higher than 
a decade before. 
Dialysis patients may be faced with serious stressors related to the illness 
and its treatment, arising from the chronic nature of kidney disease and the 
intrusiveness of the medical treatment (Parmer, 2002; Ruggenenti, Schieppati, & 
Remuzzi,2001). For this dissertation study's purposes we will focus on those 
patients being treated via HD. 
Challenges of HD treatment include adherence to fluid restriction as well 
as additional food restrictions. Patients are often confronted with physical 
symptoms such as restless legs syndrome (RLS), itching, pain, nausea, rashes, 
mood changes and lack of energy and fatigue. Additional psychological 
stressors include feelings of uncertainty about the future as well as feelings of 
guilt towards family members; and with problems in the social domain (Timmers, 
et. aI., 2008; Harwood & Wilson, 2008; Logan, Pelletier, & Hodgins, 2006; Tyrell, 
et. aI., 2005). 
Challenges may lead to a negative perception of illness. 
We know this because Timmers, et. al. (2008) observed 91 HD and 42 
peritoneal dialysis (PO) patients) participating in the NECOSAD-study. The 
authors used the Illness Perceptions Questionnaire - Revised (IPQ-R) to 
measure illness perceptions and the Short Form - 36 (SF-36) to measure quality 
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of life (QoL). They found that illness perceptions impairment contributes 
significantly to aspects of QoL in HO patients with Type 2 OM. Perceptions of 
more symptoms, more negative consequences, strong illness identity, and lower 
personal control were associated with lower well-being and a diminished QoL 
While there are multiple theories to address illness perceptions, the 
Common Sense Model (CSM) (Figure 1) based on Leventhal's Self-Regulation 
Model (SRM) provides a theoretical framework for the concept of illness 
perceptions in relation to coping behaviors and measurable outcomes such as 
well-being, QoL, and self-management (Cameron, 2003). There are five (5) 
domains to the CSM (Figure 2). They include: 1} identity; 2) cause; 3) timeline; 
4) consequences; and 5) controllability. The CSM was used to develop three (3) 
tools: 1) Illness Perceptions Questionnaire (IPQ); 2) Illness Perceptions 
Questionnaire - Revised (lPQ-R); and 3) Brief Illness Perceptions Questionnaire 
(Brief IPQ). 
Table 1 illustrates a comparative overview of the 3 tools noted in the 
literature regarding illness perceptions (Weinman, et. aI., 1996; Moss-Morris, et. 
aI., 2002; Broadbent, et. aI., 2005). Although the Brief IPQ has the lowest 
Cronbach's alpha compared to the IPQ and IPQ-R, it is still good and acceptable 
(Cronbach's alpha value = 0.75), especially given the rapid assessment format 
for both respective tools. 
Another area that has been looked at is empowerment and how the same 
aforementioned challenges affect a person's empowerment. 
Challenges may lead to a decrease in empowerment. 
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What is meant by empowerment is best described by Funnel & Weiss's 
(2009) definition that helping patients discover and use their innate ability to gain 
mastery over their disease. Patients clearly understand this tenet, as evidenced 
when they make statements like, "You can teach me, but you can't make me." 
Empowerment has been associated with positive outcomes such as improved 
diabetic control in children of empowered mothers; and improved self-care, self­
efficacy and depression in H 0 patients. 
Tsay & Hung (2004) observed 50 patients (empowerment group, n = 25; 
control group, n =25) on dialysis, which demonstrated the potential benefits of a 
concentrated, nurse-coordinated program to encourage patient self-management 
and empowerment using the Diabetes Empowerment Scale (DES) to measure 
empowerment. 
There are two (2) tools related to empowerment noted in the literature: 1) 
Diabetes Empowerment Scale (DES); and 2) Diabetes Empowerment Scale ­
Short Form (DES-SF). The three (3) subscales for both tools are as follows: 1) 
managing the psychosocial aspects of OM; 2) assessing dissatisfaction and 
readiness to change; and 3) setting and achieving goals. 
Table 2 illustrates a comparative overview of the two (2) tools noted in the 
literature regarding empowerment. The DES-SF has a good validity/reliability 
characteristic given the Cronbach's alpha value is = 0.85; and has the strength of 
a rapid assessment format. 
Based on the literature, we know that: 1) challenges may lead to a 
negative perception of illness; and 2) challenges may lead to a decrease in 
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empowerment. However, what we do not know is whether there is an 
association between illness perceptions and perceptions of empowerment and 
why this may be important? It is important to study this concept because if we 
can identify an association between illness perceptions and perceptions of 
empowerment - we can examine how to modify illness perceptions impairment. 
Therefore, indirectly address empowerment. 
Purpose of the Study 
The purposes of this dissertation study were: 1) to examine if there is an 
association between illness perceptions and perceptions of empowerment in HO 
patients with Type 2 OM; and 2) to investigate what differences in illness 
perceptions and perceptions of empowerment exist between HO patients with 
Type 2 OM and non-dialysis patients with Type 2 OM. 
Figure 3 provides the schematics for the theoretical framework for the pilot 
study, which ultimately served as the foundation of this dissertation study, which 
suggests that illness perceptions and perceptions of empowerment may 
influence one another. The primary investigator (PI) hypothesized that there is 
an association between illness perceptions and perceptions of empowerment. In 
addition, the PI hypothesized that if a HO patient with Type 2 OM has poor illness 
perceptions, then he or she also has a decrease in empowerment. Surprisingly, 
this was not the case - as will be covered within the dissertation findings section. 
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Research Questions 
Five (5) principal research questions frame this study, as follows: 1) Is 
there a difference in empowerment between HO patients with Type 2 OM (Group 
1) and non-dialysis patients with Type 2 OM (Group 2)?; 2) Is there a difference 
in illness perceptions between HO patients with Type 2 OM (Group 1) and non­
dialysis patients with Type 2 OM (Group 2); 3) Is there an association between 
illness perceptions and empowerment in HO patients with Type 2 OM (Group 1 )?; 
4) Is there an association between illness perceptions and empowerment in non­
dialysis patients with Type 2 OM (Group 2)?; and 5) Is there a difference in 
association between illness perceptions and empowerment in patients with Type 
2 OM who are receiving HO treatment (Group 1) and non-dialysis patients (Group 
2) who are not? 
Study Implications 
This dissertation study provides a better understanding of illness 
perceptions of HO patients with Type 2 OM and their association with perceptions 
of empowerment and how this association impacts QoL - to the current body of 
literature available. Since there is not enough literature on this topic, the 
outcomes of this dissertation study, therefore, provide a foundation for and 
insight regarding HO patients with Type 2 OM. 
Findings from this dissertation study may positively impact educational 
threads by bringing attention to the need for nephrology healthcare providers to 
identify HO patients' (with Type 2 OM) illness perceptions and their association 
with perceptions of empowerment. By modifying illness perceptions 
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impairments, empowerment can, therefore, be indirectly addressed. Educational 
interventions for this patient population may then be designed, specifically for 
identification and coping strategies, ultimately increasing QoL. Subsequently, 
this can provide a basis for developing interventions aimed at altering patients' 
illness perceptions to improve perceptions of empowerment. 
- 10­
Chapter II 

REVIEW OF LITERATURE 

The purposes of this dissertation study were: 1) to examine if there is an 
association between illness perceptions and perceptions of empowerment in HO 
patients with Type 2 OM; and 2) to investigate what differences in illness 
perceptions and perceptions of empowerment exist between HO patients with 
Type 2 OM and non-dialysis patients with Type 2 OM. 
The first section of this chapter explores challenges that HO patients with 
Type 2 OM face and how they may negatively affect illness perceptions, which 
result in lack of ability to self-manage their disease (for example, diabetes self­
care, adhere to fluid restrictions, etc.). The underlying theoretical framework 
guiding the study, research related to illness perceptions, and the survey 
instruments will be discussed. The second section explores the previously 
discussed challenges that HO patients with Type 2 OM face and how they may 
decrease empowerment. Subsequent sections explore how nephrology 
healthcare providers observe negative illness perceptions and decreased 
empowerment separately (in isolation) in HO patients with Type 2 OM. A 
summary of the review of literature concludes the need to observe illness 
perceptions and perceptions of empowerment via dissertation study to explore 
whether there is an association between illness perceptions and perceptions of 
empowerment in this patient population. 
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Challenges HD Patients with Type 2 DM Face 
Diabetes mellitus is a chronic illness caused by an error in carbohydrate 
metabolism that affects over 16 million individuals in the U.S. The chronic nature 
of DM1 presents considerable physiological and psychological concerns. This 
study explores illness perceptions in HD patients with Type 2 DM and whether 
there is an association with perceptions of empowerment. 
In addition, daily challenges and adjustments in lifestyle are required by 
patients with DM, who are continuously interacting with some aspect of the 
chronic illness. Diabetes is a self-managed disease with the patient providing 
95% or more of their own daily care (Anderson, et. aI., 2000). Patients make 
daily decisions involving nutrition, physical activity, medication, blood glucose 
monitoring, and stress management. Patients interact with healthcare 
professionals, family, friends, and employers for continued support to manage 
the disease. 
In adults 20 - 74 years of age, DM is the leading cause of ESRD, 
blindness, non-traumatic limb amputations and cardiovascular morbidity and 
mortality in the U.S. (ADA, 2001). Diabetes contributes to increased risk of 
stroke, by 2 to 4 times higher than adults without DM. 
I There are two types of OM, namely Type 1 and Type 2 OM. Type 1, previously known as 
juvenile-onset diabetes, is caused by the destruction of the beta cells at the pancreatic level 
resulting in insulin deficiency. Type 1 accounts for 5 percent of the OM patient population (AOA, 
2001). 
Type 2 OM, previously known as adult onset diabetes, is characterized as insulin deficient and/or 
insulin resistance. Type 2 OM accounts for 95 percent of the OM patient population. The risk of 
developing this form of OM increases with age, obesity, and lack of exercise (AOA, 2001). In 
addition, there is a strong genetiC predisposition for developing Type 2 OM. This type is more 
frequently seen in individuals with a history of gestational diabetes, hypertension, and/or 
dyslipidemia. Type 2 OM frequently goes undiagnosed for many years because there is a 
gradual onset of signs and symptoms of hyperglycemia, which may not be recognized by the 
individual or brought to the attention of a healthcare professional (NCCOPHP, 2009). 
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The challenge of DM is tackled on three (3) fronts: 1) primary prevention; 
2) secondary prevention (of complications associated with DM); and 3) tertiary 
prevention of morbidity and mortality from established complications (associated 
with DM). The complications of diabetes are preventable through tight metabolic 
control and comprehensive risk reduction (Dagogo-Jack, 2002). The challenge 
is to empower the individual through promotion of lifestyle and self-care practices 
to improve glycemic control2; and ultimately, decrease the risks of DM related 
complications. Education and empowerment are critical to the successful self-
management of DM (Anderson, et. aI., 1995). 
As of December 31,2007, nearly 111,000 people living in the U.S. have 
ESRD3. Of those ESRD patients, 44% (48,871) also have DM (either Type 1 or 
Type 2) (USRDS, 2009). 
2 Among patients beginning ESRD therapy in 2007, the average glycemic control appears to be at 

a glycosylated hemoglobin (HbA1c) level of 7.3 percent. This suggests that one in every two 

patients with ESRD and DM has less than optimal glycemic control, based on guidelines from the 

American Diabetes Association, which target a HbA1c level of less than 7 percent. Nearly 4 in 10 

diabetic patients starting ESRD therapy in 2007 had an HbA1c level of 7 percent or above 

(USRDS, 2009). Glycemic control appears to be an issue in the population starting HD with Type 

2 DM as a primary or complicating condition. (USRDS, 2009). 

3 End stage renal disease occurs when the kidneys irreversibly fail to carry out normal function. 

Kidney failure has many causes, including cancer, diabetes, hypertension, inflammation, 

infection, lupus, an arteriosclerosis (Faris, 1994). Symptoms include: poor appetite, vomiting, 

bone pain, headache, insomnia, itching, dry skin, malaise, fatigue with light activity, muscle 

cramps, high urine output or no urine output, recurrent urinary tract infections, urinary 

incontinence, pale skin, bad breath, hearing deficit, detectable abdominal mass, tissue swelling, 

irritability, poor muscle tone, change in mental alertness, metallic taste in mouth, and restless 

legs syndrome (RLS) (Sakkas, et. aI., 2008; Smith &Tolson, 2008; NKDEP, 2008; Davison, 

2007). 

How to test for ESRD. Glomerular filtration rate (GFR) is a test used to measure the level of 

kidney function and determine the appropriate stage of kidney disease. Most commonly, GFR is 

a calculation based on results of patients': 1) blood creatinine test; 2) age; 3) race; and 4) 

gender. Glomerular filtration rate is expressed in milliliters per minute (mllmin), which is a 

measure of rate at which kidneys filter blood; therefore, ESRD is essentially defined by GFR 

«1Smllmin) (Lucas, et. aI., 2008; NKDEP, 2008). 

5 stages of chronic kidney disease (CKD). There are S stages of CKD. Stage S (or ESRD) is 

defined as kidney failure (in which dialysis or kidney transplant is necessary) - with a GFR of 

<1Sml/min (Davison, 2007). 
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In 2007, the calculated rate of new ESRD cases was 354 per million 
patient population. Diabetes mellitus was the primary cause of ESRD for 54 
percent of all new patients in 2007 (USRDS, 2009). The overall adjusted rate of 
ESRD due to DM was 155 million per population in 2007; 36 percent higher than 
a decade before. 
Patients on HD are subjected to an ongoing onslaught of therapies and 
lifestyle changes that affect their psychological and psychosocial well-being. 
Patients are asked to make daily decisions about adhering to scheduled 
appointments, taking prescribed medicine, limiting the intake of fluid and certain 
foods, and managing the symptoms of chronic kidney disease (CKD). The 
challenges associated with living with CKD are significant and may contribute to 
patients feeling that they have lost control of their lives (McCarley, 2009). 
Sample challenges include: 1) maintaining meaningful life roles (such as job, 
family, friends); 2) coping with fear, anger, frustration, sadness of a chronic 
condition; 3) accepting disruption in routines; 4) confronting their own mortality; 
5) ensuring adequate dialysis care; 6) adhering to described therapies; and 7) 
adjusting to lifestyle changes (McCarley, 2009; Bodenheimer, et. aI., 2002; 
Curtin, et. aI., 2002; Shatell & Witten, 2005). 
Primary treatment of kidney disease. Dialysis is a procedure that is 
performed routinely on patients with kidney disease (especially in its final stage, 
ESRD). Dialysis is an artificial way of filtering the blood. It is a necessary 
treatment for patients diagnosed with ESRD (unless kidney transplantation is 
available). Kidneys are the organs that filter out waste products and water from 
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the blood. In ESRD, kidney function has decreased to 10% to 15% of its original 
functioning, which is life-threatening without treatment. There are two dialysis 
modalities. When kidneys fail to function, dialysis can clean waste products 
artificially. There are 2 forms of dialysis: 1) hemodialysis (HD): a kidney 
machine that filters the blood; the blood is purified by an external artificial kidney; 
and 2) peritoneal dialysis (PD): an exchange process that uses the lining of the 
inside of the abdomen as a filter (Yung, 2008; Brodin, 2001); the peritoneal 
membrane functions as an artificial kidney. For this dissertation study's 
purposes, the focus will be on those patients being treated via HD (vs. PD). 
Challenges May Lead to a Negative Perception of Illness 
Illness Perception Impainnent in HO Patients with Type 2 OM 
The enormous impact of HD treatment and diabetes care on quality of life 
(QoL) has been emphasized in many studies (Timmers, et. aI., 2008; Morsch, 
Goncalves, & Barros, 2006; Cleary & Drennan, 2005; Hagren, et. aI., 2005; 
lIiescu, et. aI., 2003; Lindqvist, Carlsson, & Sjoden, 1998). From previous 
studies it is known that QoL in HD patients with Type 2 DM is dramatically lower 
than that of the general population. Illness perceptions impairment contributes 
significantly to aspects of QoL in HD patients with Type 2 DM. 
Theories of Illness Perceptions 
Self-Regulation Theories and the Common Sense Model (CSM). In recent 
years, the term "self-regulation" has been applied to many theories. Therefore, 
there has been speculation about how self-regulation theories differ from other 
models of health and illness behavior. What differentiates self-regulation 
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theories from other models of health and illness are the elements of feedback, 
motivation, and the goal of pursuit. Self-regulation theories suggest that people 
have two inherent overarching goals: 1) survival; and 2) coherence. When 
illness threatens one's survival and sense of coherence, cognitive, motivational, 
and behavioral patterns that develop during illness may determine how one will 
adapt to the illness (Cameron & Leventhal, 2003). Managing an illness: 1) 
challenges the integrity of self; 2) requires regulation of emotional and physical 
states; and 3) requires understanding of the personal meaning connected to 
health related goals and behaviors. Self-regulation of illness often occurs within 
a dynamic social context of family members and friends that allow for the sharing 
of ideas and emotions. The Common Sense Model (CSM) of self-regulation 
developed by Leventhal, et. aI., (1984) was developed specifically to understand 
and explain health and illness behavior (Cameron & Leventhal, 2003). 
The CSM of self-regulation is based on a parallel processing system 
consisting of two (2) pathways: 1) abstract cognitions (feelings of vulnerability); 
and 2) concrete experience (symptoms) (Figure 1). These pathways interact as 
an individual adapts to an illness by creating coping procedures to manage the 
emotions and the symptoms (Leventhal, Brissette & Leventhal, 1992; Whitmarsh, 
Koutantji, & Sidell, 2003). Individuals construct representation of illness based 
on these pathways for which they generate goals of self-management and then 
derive feedback criteria to evaluate the response efficacy. According to the CSM 
there are five (5) domains of illness representation including: 1) identity; 2) 
timeline; 3) consequences; 4) control; and 5) cause (Figure 2). 
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Each domain is comprised of countless variables that stem from a 
complex social biological system. Individual appraisals of social and cultural 
factors as well as the experiences of their disease such as pain, fatigue, nausea, 
rashes, disruptions in cognitive or physical functioning, and mood changes are 
powerful contributors to the illness representation (Leventhal, et. aI., 1992). 
Illness representations evaluating the acute, chronic, or cyclic nature of the 
disease are often based on communications with healthcare professionals, family 
members, and other patients rather than the actual biology of the disease. A 
patients' perspective on aspects such as his or her age, expected longevity, 
assessment of overall health, and immune strength interacts with his or her 
perception of each of the five domains of illness representation (respectively, 
identity, timeline, consequences, control, and cause). The association between 
patients' perspective and illness representations then plays a role in determining 
which coping procedure will be most helpful to him or her to manage illness 
(Leventhal, et. aI., 1984; Leventhal, Diefenback, & Leventhal, 1991; Leventhal, 
et. aI., 1992). 
Understanding why patients do not adhere to medical regimen has been 
conceptualized using the CSM and illness representations. Individuals seek 
coherence between their illness representations and the procedures to cope with 
their disease, which includes their perceptions of treatment necessity (Horne, 
2003). These evaluations are influenced by the information individuals receive 
about types and classes of treatment, past treatment experiences of one's self 
and others as well as societal and cultural norm about treatment. Horne (2003) 
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explained the unique relationship each of the CSMs' five illness representations 
including: 1) identity; 2) timeline; 3) consequences; 4) control; and 5) cause, has 
with the perception of treatment necessitl. 
Although the theoretical framework of the CSM suggests that self-efficacy 
(one component of empowerment), or the ability to engage in various situation-
specific self-management tasks (Anderson, et. aL, 2000) (such as meal planning, 
adhering to scheduled appointments or blood glucose monitoring) to medical 
regimens is a form of coping procedure (Llewellyn, et. aL, 2003), no research 
projects have evaluated the CSM with patients' empowerment (as of date; to the 
best of the authors' knowledge). 
Illness perceptions are also related to perceptions of treatment necessity, 
which in turn, may influence empowerment, which will be discussed in 
subsequent sections. 
Research Related to Illness Perceptions 
Timmers, et. aL (2008) conducted a study titled, "Illness perceptions in 
dialysis patients and their association with quality of life." Their study explored 
illness perceptions of patients with ESRD (on both HD and PD). and their 
association with quality of life (QoL). Leventhal's self-regulation model (SRM) 
4 Identity - assesses the symptoms experienced by the patient. Perceptions of treatment 
necessity are influenced by symptoms and the absence of severe symptoms or side effects may 
lead to the perception that treatment is not necessary or not working properly (Leventhal, et. aI., 
1984). Consequences and time/ine - symptoms often used in determining illness representations 
about timeline and personal consequences of a condition. Treatment necessity is more 
convincing if it is consistent with the individual'S representations of his or her illness. Causal 
attribution - causal beliefs have not been found to be strongly relations to the patients' sense of 
treatment necessity. Horne (2003) suggests that causal beliefs do not vary much between 
patients with the same illness. Control/Cure - treatment necessity is correlated with efficacy 
belief, or the belief that the illness will be controlled by the treatment but not with other types of 
beliefs such as chance or personal control. 
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was used as a theoretical framework. Illness perceptions and QoL were 
assessed with the Illness Perceptions Questionnaire - Revised (lPQ-R) and the 
Short Form - 36 (SF-36) in 91 HO and 42 PO patients participating in the 
NECOSAO-study. Compared to HO patients, PO patients experienced more 
personal control and had a better understanding of the illness. Illness 
perceptions explained 'from 17 to 51 percent of the variance in QoL scores. 
Perception of more symptoms, more consequences, strong illness identity, many 
negative consequences, and lower personal control were associated with lower 
well-being. Higher identity and higher control are associated with a better 
outcome, and more perceived outcomes, higher emotional representations and 
less control being associated with worse outcomes (Timmers, et. aI., 2008). 
The concept of illness perceptions is useful in understanding the impact of 
ESRO and of dialysis treatment on QoL. The above authors concluded that 
interventions aimed at providing more knowledge about ESRO and dialysis, and 
provision of skills to coping with the illness and its consequences may improve 
QoL in dialysis patients. 
With the increasing interest in the CSM based on Leventhal's SRM, 
Weinman, et. aI., (1996) created the Illness Perception Questionnaire (IPQ). The 
IPQ was utilized by the aforementioned research to assess the five dimensions 
of the CSM (Le., identity, timeline, consequences, cure/controllability, and cause) 
and the patients' overall illness perception. Since its construction, the IPQ has 
been utilized to examine adherence in chronic illnesses such as asthma, 
diabetes, heart disease, breast cancer, and Huntington's disease. 
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One of the first studies conducted using the IPQ was in 1999 by two of the 
authors of the IPQ, Horne and Weinman. They examined patients' beliefs about 
treatment adherence in chronic physical illness. This study found considerable 
variation within and between chronic illness groups on patients' self-reported 
adherence and their beliefs about medication (Horne & Weinman, 1999). One of 
the limitations of this study included having a cross sectional design of chronic 
illnesses. Because each illness was unique in terms of its symptomology and 
etiology and each patient had differing perceptions of their illnesses, it was 
difficult for the authors to conclude how the patients' illness perceptions 
influenced treatment adherence. This limitation had not been a problem for the 
majority of studies utilizing the IPQ because these other studies focused on 
research using a single illness population rather than multiple illnesses. 
In 2000, Byer and Meyer utilized the IPQ to look at medication adherence 
in asthma patients. The authors found patients' beliefs abut the necessity of 
medication, duration of illness, and identity about illness all influenced patients' 
adherence to medication. The generalization of their findings was limited by the 
fact that their participants were drawn from one primary care setting. In contrast, 
Horne and Weinman (2002) examined adherence to asthma medication from 
patients attending asthma clinics from multiple sites. Their results suggested that 
illness perception and treatment beliefs were the strongest predictors of 
adherence. In this study, adherence was measured by self-report, which is a 
subjective measure (Horne & Weinman, 2002). The authors acknowledged that 
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although self-reported adherence was a commonly used method in medical 
research, an objective measure offered a different perspective on adherence. 
Griva, Myers, and Newman (2000) examined patient HbA1c levels in 
addition to patients' self-report of adherence. HbA1c levels are blood samples 
that measure diabetic patients' metabolic control over a 6 to 12 week time period 
and are an excellent physiological indicator of treatment adherence. The 
participants were insulin dependent diabetic patients recruited from multiple 
clinics to examine their illness perceptions and adherence. The researchers 
found a different pattern of associations between self-reported adherence and 
the HbA1c levels. Perceived Illness Identity was the only scale from the IPO 
found to be associated with patients' self-reported adherence whereas Perceived 
Consequences was the only scale from the IPO to be significantly correlated with 
the objective measure of adherence (i.e., the HbA1c levels). These results 
demonstrated how different adherence measures are related to different 
dimensions of illness perceptions and they caution that interpretation of results is 
necessary. 
Another study conducted by Llewellyn, et. al. (2003) with hemophilia 
patients utilized treatment records as an objective measure of adherence and did 
not include a self-report measure. In their results, only Identity from the IPO was 
found to be a predictor of adherence in hemophilia patients. As with the 
previously mentioned hemodialysis (HD) adherence literature, a major limitation 
of these IPO research projects was lack of design and statistical procedures to 
examine the direction of causation between IPO dimensions and adherence. 
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The aforementioned IPO studies used cross sectional designs, retrospective 
adherence measures, and correlation statistics. 
In 2003, Whitmarsh, et. al. conducted a prospective study using illness 
perceptions to evaluate attendance to cardiac rehabilitation. They found that 
lower perception of symptoms and Controllability/Curability of illness was the 
best predictors of poor attendance records at rehabilitation sessions. While 
patients' illness perceptions were measured before the start of the rehabilitation 
program, the researchers did not account for other psychosocial influences that 
may have contributed to poor attendance. The utility of the IPO as a prospective 
assessment instrument for poor attendance has been developed by this research 
for cardiac rehabilitation programs. 
In addition to the IPO being utilized with traditional Western medicine 
adherence, Searle and Murphy (2000) examined cognitive representations of 
new homeopathic patients and the extent of their adherence to recommended 
treatment. The patients presented with a myriad of medical concerns. The study 
found that patients' Causation beliefs were found to be the best predictor of 
illness understanding and treatment adherence. 
In addition to the research examining illness perception as a predictor for 
treatment adherence, other researchers have used the IPO to examine patients' 
illness perceptions as mediating and/or moderating psychosocial variables. 
Rees, et. al. (2003) also included illness perception in a study examining distress 
in women with an increased risk for breast cancer. They compared samples of 
women with an increased risk of breast cancer and those who are not at risk, and 
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compared their illness perception and distress. There were no discernable 
differences between the two risk groups' illness perceptions and their levels of 
distress. 
The IPQ has also been modified to address caregivers' illness perceptions 
as well as the patients with Huntington's disease. In two separate but related 
studies, Helder, et. al. (2002) examined how illness perception contributed to 
caregivers' QoL and patients' well-being. Illness Identity, Consequences, and 
Timeline were found to be correlated to caregiver coping, however, did not 
significantly explain the caregivers' QoL. In the second study, Helder, et. al. 
(2002) focused on the illness perception of Huntington's disease patients and 
found that patients' illness Identity was negatively related to their well-being. 
Inclusion of the IPQ in the Huntington's disease studies allowed the IPQ to 
assess patients whose illness is virtually untreatable. 
The ability to treat a patients' condition and how this relates to their 
perception of illness was also examined by Fortune, et. al. (2002) in a study of 
psoriasis. Psoriasis is a chronic, skin disease that is incurable. The authors 
used the IPQ with this difficult to treat and incurable patient population. This 
study found that illness perceptions as measured by the IPQ explained the most 
amount of variance for stress, distress, and disability in patients with psoriasis. 
Tools Related to Illness Perceptions 
There are three (3) tools related to illness perceptions that can be used for 
this study: 1) Illness Perceptions Questionnaire (or IPQ); 2) Illness Perceptions 
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Questionnaire - Revised (or IPQ-R); and 3) Brief Illness Perceptions 
Questionnaire (or Brief IPQ). See Table 1. 
Based on the utilization and adaptability of the IPQ with different patient 
population and illnesses, Moss-Morris, et. al. (2002) re-evaluated the IPQ and 
decided to revise it to make it more accurate to the theoretical tenets of CSM 
based on Leventhal's SRM, and improve the psychometric properties of the 
Cure/Control and Timeline subscales. The IPQ-R increased the Cronbach's 
alpha score to 0.89 for the timeline subscale and separated the Cure/Control 
subscale into three (3) separate subscales that more accurately assessed the 
patient's perceptions of: 1) cure; 2) illness control; and 3) treatment control 
(Moss-Morris, et aI., 2002). 
Fowler and Baas (2006) used the IPQ-R to examine the illness 
representation of patients on HD. The authors explored the relationship between 
illness perception and QoL for CKD patients on maintenance HD. These authors 
found a strong relationship between the QoL and patients' illness perceptions, 
suggesting further examination of illness perceptions and holistic outcomes in 
persons undergoing HD. This research had limitations including a 24.7% 
response rate, which produced a small sample size. The authors postulated that 
a thorough assessment of patients' perceptions may provide the medical team 
with substantial information about how patients perceive HD in terms of illness 
Identity, Cause, Timeline, Consequences, and Control/ability. Identifying and 
addressing patients' perceptions may improve adherence with recommended 
treatment regimens. 
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In 2005, Broadbent, et. al. evaluated the Brief IPO, a nine-item scale 
designed to rapidly assess the cognitive and emotional representations of illness. 
The researchers assessed the test-retest reliability of the scale in 132 renal out­
patients. They assessed concurrent validity by comparing the Brief IPO with the 
IPO-R and other relevant measures in 309 asthma, 132 renal, and 119 diabetes 
out-patients. Predictive validity was established by examining the relationship of 
Brief IPO scores to outcomes in a sample of 103 myocardial infarction (MI) 
patients. Discriminant validity was examined by comparing scores on the Brief 
IPO between five (5) different illness groups. The findings indicated the Brief IPO 
showed good test-retest reliability and concurrent validity with relevant measures. 
The scale also demonstrated good predictive validity in patients recovering from 
MI with individual items being related to mental and physical functioning at 3 
months' follow-up, cardiac rehabilitation class attendance, and speed of return to 
work. The discriminant validity of the Brief IPO was supported by its ability to 
distinguish between different illnesses. In sum, the Brief IPO provides a rapid 
assessment of illness perceptions, which could be particularly helpful in ill patient 
populations, large-scale studies, and in repeated measures research designs 
(Broadbent, et. ai., 2005). 
The IPO-R has over 80 items, and in some situations such a long 
questionnaire is prohibitive. This is particularly the case with HD patients with 
Type 2 DM because patients are very ill and the primary treatment is long and 
invasive. A shorter questionnaire such as the Brief IPO (vs. IPO or IPO-R) is 
more suitable because it is less taxing and much quicker to complete. Also, it is 
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more acceptable to those patients (particularly older adults) who are limited in 
their reading and writing ability. The Brief IPQ offers the potential for illness 
perceptions to be investigated in a wider range of patient groups and would be 
especially useful when illness perceptions are measured as only one part of a 
larger set of psychological constructs (as is the case in this dissertation study) 
(Broadbent, et. aI., 2005). 
Details of the Illness Perception Questionnaire - Revised (lPQ-R). The 
psychometric properties of the IPQ-R have been previously tested on center­
based HD patients, and the structural validity, internal reliability, test-retest 
reliability, and discriminant validity are within acceptable limits (Moss-Morris, et. 
aI., 2002). The internal reliability for each dimension of the IPQ-R was 
demonstrated by Cronbach's alpha scores ranging from 0.79 to 0.89. 
The IPQ-R assesses nine components of illness representation in three 
(3) sections. The first section asks about the subscale Identity - In which 
participates are asked yes/no questions about 14 different symptoms and if they 
believe these symptoms are related to being on HD. 
The second section is comprised of 38 questions address 7 subscales 
(Moss-Morris, et. aI., 2002). Two (2) subscales are patient's perception of control: 
1) Personal control (beliefs about the control he/she has in controlling their 
symptoms and condition); and 2) Treatment control (beliefs about the usefulness 
of the treatments they are receiving). The next two scales assess Time/ine 
(length of time that the patient believes HD will last) and Timeline cyclical 
(patients' perceptions about the patterns of how they are feeling). The last three 
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scales are: Consequences (patient's expected outcomes and effects of HD); 
Illness coherence (an overriding dimension of how much patients 
understand/comprehend about their illness); and Emotional representation (six 
affective responses which are sensitive to illness perception and to predict health 
related responses). All scales are scored using a 5-point Likert scale: strongly 
agree, agree, neither agree nor disagree, disagree, strongly disagree. Each 
subscale is scored separately with some reverse-scoring required. 
High scores on identity, timeline, consequences, and cyclical scales 
demonstrate strongly held beliefs about the number of symptoms attributed to the 
illness, the chronicity of the condition, the negative consequences of the illness, 
and the cyclical nature of the condition, respectively. High scores on the 
personal control, treatment control, and coherence dimensions theoretically 
represent positive beliefs about the controllability of the illness and a personal 
understanding of the condition (Moss-Morris, et. aI., 2002). 
The third and final section foclJses on the subscale Causes. This scale 
consists of 18 possible causes for being on dialysis (i.e., lifestyle, hereditary, 
chance, behavior, uncertain). This scale also uses the 5 point Likert scale. 
Strengths and limitations of the IPQ-R. The IPQ-R is a subjective 
measure of illness representations or perceptions (Moss-Morris, et. aI., 2002). 
Strengths include: 1) self-reporting can empower the patient; and 2) the scale 
has been adapted to enable the patient to respond in various languages. 
Limitations include: 1) the questionnaire is very long (over 80 items); and 2) the 
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questionnaire is difficult for patients who are limited in their reading and writing 
ability. 
Details of the Brief Illness Perception Questionnaire (Brief IPQ). The Brief 
IPO is a psychosomatic scale, which can be used to include HD patients with 
Type 2 DM with the permission of the authors (Appendix C; Appendix H). See 
Table 1. 
The psychometric properties of the Brief IPO (Appendix C) have been 
previously tested on center-based HD patients, and the structural validity, internal 
reliability, test-retest reliability, and discriminant validity are within acceptable 
limits (Broadbent, et. aI., 2005). The internal reliability for each of the five (5) 
dimensions of the Brief IPO was demonstrated by Cronbach's alpha scores 
ranging from 0.70 to 0.75. 
The Brief IPO has nine (9) items and is shown in Appendix C. The items 
were developed by forming one question that best summarized the items 
contained in each subscale of the IPO-R. Therefore, the Brief IPO has eight (8) 
new items plus part of the causal scale previously used in the IPO-R. All of the 
items except the causal question are rated using a 0-to-10 response scale. Five 
(5) of the items assess cognitive illness representations; consequences (Item 1), 
timeline (Item 2). personal control (Item 3), treatment control (Item 4), and 
identity (Item 5). Two (2) of the items assess emotional representations: 
concern (Item 6) and emotions (Item 8). One item assesses illness 
comprehensibility (Item 7). Assessment of the causal representation is by an 
open-ended response item adapted from the IPO-R, which asks patients to list 
- 28­
the three (3) most important causal factors in their illness (Item 9). Responses to 
the causal item can be grouped into categories such as stress, lifestyle, 
hereditary, etc., determined by the particular illness studied, and categorical 
analysis can then be performed (Broadbent, et. aI., 2005). For this dissertation 
study's purposes, responses to Item 9, causal factors, were collected (perhaps 
for future use), however, were not included in the results. 
Like the IPQ and IPQ-R, the Brief IPQ uses the word 'illness', but it is 
possible to replace this with the name of a particular illness (such as kidney 
disease or ESRO and OM or Type 2 OM, specifically). Similarly, the treatment 
control item uses the word 'treatment', but this can be replaced by a particular 
treatment (such as 'hemodialysis'), if researchers are interested in a particular 
treatment (Broadbent, et. aI., 2005). For this dissertation study's purposes the 
words 'illness' and 'treatment' were not replaced. 
Strengths and limitation of the Brief IPQ. The Brief IPQ (Appendix C) is a 
subjective measure of illness representations or perceptions (Broadbent, et. aI., 
2005). Strengths include: 1) brevity; 2) speed of completion for patients; 3) easy 
interpretation of scores; 4) useful for ill and elderly populations who would 'find 
completion of a long questionnaire (such as the IPQ or the IPQ-R) difficult; 5) 
advantageous when researchers are already using a other pencil-and-paper 
measures but wish to also include an assessment of illness perceptions; 6) 
advantageous when researchers need to assess illness perceptions repeatedly 
over a relatively short period, to reduce the burden on research participants; 7) 
valid and reliable measure of illness perceptions in a variety of illness groups 
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(including HO patients with Type 2 OM and non-dialysis patients with Type 2 
OM); 8) easy to understand and to complete for patients; 9) results from the scale 
can be easily scored and are readily interpretable by researchers and clinicians; 
and 9) the scale has been adapted to enable the patient to respond in various 
languages. A limitation is self-reporting can reflect inaccurate information if the 
patient has difficulty understanding what is written, or cannot see or physically 
write out responses (however, the questionnaire can be used with an interpreter 
in future studies, if deemed necessary). 
Challenges May Lead to a Decrease in Empowerment 
Empowerment Impairment in HD Patients with Type 2 OM 
Hemodiaysis patients with Type 2 OM make choices each day that are 
affected by their emotions, thoughts, values, goals, and other psychosocial 
aspect of living with a chronic illness (Anderson, et. aI., 1995). Type 2 OM and 
kidney disease (especially in combination) are complex chronic diseases to 
manage. In addition to its medical management, empowerment of the HO patient 
with Type 2 OM is required to overcome psychosocial barriers to self­
management and QoL (Glasgow, Toobent & Gillette, 2001; Powers, 2003; 
McCarley, 2009). 
Theories of Empowerment 
Empowerment of patients supports "a path that has a patient-centered 
approach in collaboration with the medical regimen" (Simmons, 2001, p. 12). 
The literature on the theoretical underpinnings of empowerment has 
proliferated during the last 15 years, however, there has been less emphasis on 
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the development of instruments to measure empowerment (Herbert, et aI., 
2009). Instruments that have been developed tend to be tailored for use in 
specific populations or contexts. Questionnaires measuring empowerment in 
adults focus on the individual. To contextualize this research, the origins and 
meaning of empowerment theory are discussed, as it relates to this study. 
Empowerment theory. Empowerment is a multidimensional construct 
applicable to individuals (as well as to organizations and neighborhoods). It is 
viewed as a construct (vs. a concept) because it is not directly observable. One 
of the earliest references to empowerment describes it as " ... the possibility for 
people to control their own lives" (Herbert, et. aI., 2009). Empowerment is 
commonly described as a contextual, participatory process, which enables 
individuals to achieve a sense of control over their own lives. Empowerment 
processes are essential to achieving empowerment outcomes. These processes 
are transactional in that they involve interactions with others (Herbert, et. aI., 
2009). 
Empowerment is a coercive strategy that is justified by its outcomes and 
creates dependent patient populations (Powers, 2003). Empowerment has been 
associated with positive outcomes such as improved diabetic control in children 
of empowered mothers; more active decision making and lower anxiety levels in 
men with prostate cancer; increased self-efficacy, skill, and knowledge in women 
learning about breast cancer control; and improved empowerment, self-care, 
self-efficacy, and depression in those with ESRD (Herbert, et aI., 2009; Tsay & 
Hung, 2004; Little, et. aI., 2004). 
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In the context of HD patients with Type 2 DM, empowerment is defined as 
helping patients discover and use their innate ability to gain mastery over their 
disease (Funnel & Weiss, 2009). Patients clearly understand this tenet, as 
evidenced when they make statements like, "You can teach me, but you can't 
make me." Moreover, interest in empowerment grew out of recognition that the 
traditional compliance or adherence models of care for ESRD patients 
undergoing HD treatment and education does not always work. Thus, this is not 
a new way of looking at adherence or a new method of trying to get patients to 
follow their treatment plan, but a different paradigm for providing multi­
disciplinary care for those patients undergoing HD treatment. 
The term empowerment has been used to refer to other similar constructs, 
and in particular to self-efficacy (Anderson, et. aL, 2000; Herbert, et. aL, 2009), 
even though empowerment has a more broad theoretical perspective (vs. self­
efficacy) (Herbert, et. aL, 2009). Perceived self-efficacy is defined as the belief in 
one's own capabilities to organize and execute the actions that are required to 
produce goals. Self-efficacy has been characterized as both a component and 
an outcome of empowerment (Herbert, et. aL, 2009). 
The literature on empowerment has evolved from a primarily theoretical 
perspective, to theory testing and redefinition, with a greater focus on 
measurement (Herbert, et. aL, 2009). The context-specific nature of 
empowerment and increased emphasis on its measurement has resulted in the 
development of questionnaires designed for specific populations (such as 
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diabetes). An overview of self determination theory and its relevance to 
empowerment theory follows. 
Self-determination theory. Patient empowerment is based on the tenets of 
self-determination theory, which states that individuals are naturally motivated to 
improve their own well-being. This theory predicts improved outcomes among 
patients who approach the regulation of their own health from the perspective of 
autonomous self-regulation, competence, control, and self-determination; similar 
to self-efficacy. Self-determination theory has been consistently supported by 
study results, which show that patients are much more likely to adhere to 
recommended therapeutic approaches if they have internalized the need for a 
behavioral change and value it personally (vs. others that try to force them to 
behave in a way that is contrary to their nature) (McCarley, 2009). 
Self-determination is a term used to describe respect for a patient as an 
individual and that patients should have some control of the dialysis process in 
which the patient and healthcare professional share. This means that the patient 
is an integral part of their own care and the decision-making required. Self­
determination in a dialysis unit recognizes who owns the "body"; therefore, who 
has the right to make choices (Tims, Kling, & Bennett, 2007). 
Research Related to Empowerment 
Several landmark studies have noted that effective management of DM by 
patients who have the chronic disease is essential to prevent complications 
(ADA, 2001; Anderson, et. aI., 2000; Rubin, Peyrot, & Saudek, 1991; The 
Diabetes Control and Complication Trial Research Group, 1993; United Kingdom 
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Prospective Study Group, 1998). In these studies, it was found that effective 
management goals were established through the patient having control and 
effective self-care behaviors. Hemodialysis patients with DM need to understand 
the disease and treatment, which includes implementing changes in lifestyle 
(Hunt, Arar, & Larme, 1998). 
Healthcare professionals typically spend a significant amount of time 
trying to convince HD patients with Type 2 DM to change potentially harmful 
behaviors. Data have consistently indicated that behavior cannot be successfully 
modified unless patients set their own goals and internalize the need for change 
(McCarley, 2009). 
The need for empowered patients is highlighted by the fact that HD 
patients spend 92% of their time outside the confines of the dialysis facility. 
Therefore, self-management is necessary to ensure improved outcomes 
(McCarley, 2009). 
In one randomized controlled study titled, "Empowerment of patients with 
end-stage renal disease: a randomized controlled trial" conducted by Tsay and 
Hung (2004), 50 patients (empowerment group, n = 25; control group, n = 25) on 
dialysis demonstrated the potential benefits of a concentrated, nurse-coordinated 
program to encourage patient self-management and empowerment. Qualified 
participants from two (2) dialysis centers of major hospitals in southern Taiwan 
were randomly assigned into control and experimental groups. Each group 
received identical packets of information on CKD, potential therapies, coping 
strategies, and other components of care. In addition, the experimental group 
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participated in twelve one-on-one consulting sessions in which nurses fostered 
empowerment by helping patients develop self-management skills (including goal 
setting, problem solving, stress management, coping techniques, social support, 
and motivation). A patient-led behavioral change program encouraged patient 
identification of problem areas that could be addressed through self­
management, exploration of emotions. development of goals and strategies to 
achieve these goals, and a self-care plan for behavioral change and stress 
management. Patient-reported outcomes were assessed through several 
validated survey instruments. Patients' perceptions of their own empowerment 
was measured using the Diabetes Empowerment Scale (DES; please see below 
for details). which included subscales on managing the psychosocial aspects of 
disease, assessment of dissatisfaction and readiness to change, and how goals 
were set and achieved. The Strategies Used by People to Promote Health Scale 
was used to assess patients' perceptions of self-care and self-efficacy (Tsay & 
Hung, 2004). 
Data for both groups were collected at baseline and 6 weeks after 
completion of the intervention in the experimental group. Primary statistical 
analysis was performed by means of t-test and analysis of covariance. Results 
indicated significant improvements in empowerment {t(48) =6.54; P < 0.0001} 
among patients in the experimental group compared with those in the control 
group (Tsay & Hung, 2004). The results of this study highlight the complexities in 
attempting to quantify the concept of empowerment (Tims, King, & Bennet, 2007) 
for this patient population. 
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Limitations noted in this study include: 1) small sample size (n =50); and 
2) non-generalizable (may not be applicable to diverse sociodemograhic HD 
patient populations to include variables such as race or ethnicity). The sample 
for this study was drawn from two (2) dialysis centers of major hospitals in 
southern Taiwan. 
Therefore, based upon limitation, future work will incorporate the 
aforementioned Common Sense Model (CSM) based on Leventhal's Self­
Regulation Model (SRM) within the context of this dissertation study. 
Tools Related to Empowerment 
A patients' degree of empowerment should be assessed like any other 
component of therapy, and healthcare professionals should be trained to consult 
with patients to refine self-management and empowerment skills (McCarley, 
2009). 
Details of the Diabetes Empowerment Scale - Short Form (DES-SF). The 
DES-SF is an empowerment scale, which can be used for HD patients with Type 
2 DM with the permission of the Michigan Diabetes Research and Training 
Center (MDRTC) (Appendix D). See Table 2. The MDRTC developed the DES­
SF in part for the use by healthcare profeSSionals. By downloading the forms, 
the PI agreed to acknowledge the MDRTC as the source of the items in the 
survey instruments in any written instruments, reports, or publications resulting 
from their use or reproduction. 
In 2000, Anderson, et. al. developed the Diabetes Empowerment Scale 
(DES) to measure the psychosocial self-efficacy of people with diabetes. The 
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original questionnaire contained 37 items representing eight (8) conceptual 
dimensions including: 1) assessing the need for change; 2) developing a plan; 3) 
overcoming barriers; 4) asking for support; 5) supporting oneself; 6) coping with 
emotion; 7) motivating oneself; and 8) making diabetes care choices appropriate 
for one's priorities and circumstances. Using factor analyses the questionnaire 
was reduced to the current 28-item DES (alpha =0.96) containing three (3) 
subscales. The three (3) subscales are: 1) managing the psychosocial aspects 
of diabetes with 9 items (alpha =0.93); 2) assessing dissatisfaction and 
readiness to change with 9 items (alpha = 0.81); and 3) setting and achieving 
goals with 10 items (alpha =0.91). In addition to providing an overall 
assessment of diabetes-related psychosocial self-efficacy, the three (3) 
subscales of the DES allow for an examination of its underlying components. 
To allow for a brief overall assessment of diabetes-related psychosocial 
self-efficacy, Anderson, et. al. (2000) developed an eight-item short form of the 
DES (the DES-SF; Appendix D). The DES-SF was created by choosing the item 
from the remaining 28 items with highest items to subscale correlation from each 
of the original eight (8) conceptual domains. The reliability of the DES-SF using 
the original dataset was alpha =0.85. The authors subsequently administered 
the DES-SF to 229 participants in a study. The reliability of the DES-SF using 
the data from the sample was alpha =0.84. The content validity of the DES-SF 
was supported in the study by DES-SF scores and HbA1c levels changed in a 
positive direction after the 229 participants completed a 6-week problem-based 
patient education program. The change in DES-SF scores and HbA1c levels 
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were not correlated, suggesting that these two measures vary independently 
(Anderson, et. aI., 2000). These data provide evidence that the DES-SF is a 
valid and reliable measure of overall diabetes-related psychosocial self-efficacy. 
Strengths and limitation of the DES-SF. The DES-SF (Appendix D) is a 
subjective measure of empowerment for HD patients with Type 2 DM (Anderson, 
et. aI., 2000). Strengths include: 1) brevity; 2) speed of completion for patients; 
3) easy interpretation of scores; 4) useful for ill and elderly populations who 
would find completion of a long questionnaire (such as the DES) difficult; 5) 
advantageolJs when researchers are already using a other pencil-and-paper 
measures but wish to also include an assessment of empowerment; 6) 
advantageous when researchers need to assess empowerment repeatedly over 
a relatively short period, to reduce the burden on research participants; 7) valid 
and reliable measure of empowerment in a variety of illness groups (including HD 
patients with Type 2 DM); 8) easy to understand and to complete for patients; 9) 
results from the scale can be easily scored and are readily interpretable by 
researchers and clinicians; and 9) the scale has been adapted to enable the 
patient to respond in various languages. A limitation is self-reporting can reflect 
inaccurate information if the patient has difficulty understanding what is written, 
or cannot see or physically write out responses (however, the questionnaire can 
be used with an interpreter in future studies, if deemed necessary). 
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Is There an Association between Illness Perceptions and Perceptions of 
Empowerment? 
Based on the literature, we know that: 1) challenges may lead to a 
negative perception of illness; and 2) challenges may lead to a decrease in 
empowerment. However, what we do not know is whether there is an 
association between illness perceptions and empowerment and why this may be 
important? It is important to study this concept because if we can identify an 
association between illness perceptions and perceptions of empowerment - we 
can examine how to modify illness perceptions impairment. Therefore, indirectly 
address empowerment. 
Traditionally, the nephrology team (consisting of various healthcare 
professionals) focuses educational efforts on providing patients with the 
knowledge needed to comply with the prescribed treatment regimen. However, 
studies have consistently indicated that patients cannot be forced to follow a 
lifestyle that is decided by others. Therefore, patient empowerment and self­
management are crucial to ensure that patients know they are still in control of 
their lives and are motivated to become engaged partners with their nephrology 
healthcare team (McCarley, 2009). 
This dissertation study will provide a better understanding of illness 
perceptions of HO patients with Type 2 OM and their association with perceptions 
of empowerment and how this association impacts QoL. Since there is not 
enough literature on this topic, the outcomes of this dissertation study will provide 
a foundation for and insight regarding HO patients with Type 2 OM. 
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Findings from this dissertation study may positively impact educational 
threads by bringing attention to the need for nephrology healthcare providers to 
identify HD patients' (with Type 2 DM) illness perceptions and their association 
with perceptions of empowerment. By modifying illness perceptions 
impairments, empowerment can, therefore, be indirectly addressed. Educational 
interventions for this patient population may then be designed, specifically for 
identification and coping strategies, ultimately increasing QoL. Subsequently, 
this can provide a basis for developing interventions aimed at altering patients' 
illness perceptions to improve perceptions of empowerment. 
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Chapter III 

METHODS 

Study Design 
Pilot phase. The pilot study design was an exploratory one. Data was 
used to determine the sample size for this dissertation study based on power 
analysis (Erdfelder, Faul, & Buchner, 1996). Methodology was reviewed to 
ensure technical and logistical aspects were capable of being achieved. The 
pilot study confirmed the methodology including procedures was sound. 
Ultimately, the dissertation study findings were supported by the pilot study 
findings. 
Definitive study. In this dissertation study (prospective, cohort-nested, 
case-control, quantitative), a cohort (N = 101) of 51 HD patients with Type 2 OM 
(Group 1; case) was developed from among the patients of one out-patient 
dialysis center {St. Joseph's Regional Medical Center (SJRMC) located at 703 
Main Street in Paterson, NJ; Chief Nephrologist: Chandra B. Chandran, MD} in 
addition to 50 non-dialysis patients with Type 2 OM (Group 2; control) from one 
family medicine clinic at SJRMC. 
Tools 
The Brief-IPQ is a psychosomatic scale, which was used to measure 
illness perceptions of HD patients with Type 2 OM with the permission of the 
authors (Appendix C; Appendix H). 
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The DES-SF is an empowerment scale, which was used to measure 
empowerment of HD patients with Type 2 DM with the permission of the 
Michigan Diabetes Research and Training Center (Appendix D). 
Sociodemographic information. A General Information Form (GIF) (Appendix 
E) questionnaire with seven (7) dimensions of sociodemographic information was 
developed for this research including: 1) gender; 2) age; 3) length of time on 
dialysis; 4) primary language spoken at home; 5) race or ethnicity; 6) years of 
basic schooling; and 7) employment status. The Paterson public schools public 
report from the New Jersey Department of Education was used to develop the 
GIF, specifically regarding race, ethnicity, and primary language spoken at home 
(Glascoe, 2009). 
Coding of all research materials. Coding of all returned research packets 
(including all of their survey contents) was performed as follows. Each survey 
form - for each participant to be surveyed - was numbered using a gently 
pressed pencil mark on the back of each survey within the research packet (to be 
administered by administrative personnel). The contents of surveys within each 
research packet had the same number. The following numbering system was 
developed to track the results (Sexton, et. aI., 2004). The tracking number 
incorporated the month and year of the survey, which was helpful in keeping data 
organized, especially when the pilot study was approved and extended for use 
within the dissertation study, as obtained data was useful in application for the 
dissertation study (as an example of how surveys would be conducted multiple 
times). Please note codes that may obviously identify participants were not 
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used. Using the criteria previously described within the initiallRB Application 
form, the PI determined that the proposed pilot study required 40 research 
packets. The PI began conducting the pilot study in May 2010, so the research 
packets (and all of their survey contents) were numbered sequentially as 0510­
01 through 0510-40. A good response rate was essential for meaningful results; 
therefore, the PI had a response rate of at least 65 percent (n = 26) before 
analyzing and presenting the results. The PI began conducting the dissertation 
study in December 2010, so the research packets (and all of their survey 
contents) were numbered sequentially as 1210-01 through 1210-80. By using a 
numbering system with ranges, the PI was able to determine how many surveys 
have been returned; and to better maintain organization for possible future use. 
Study Participants 
All relevant permissions and ethical approval to conduct this research 
were obtained from the organizations (SHU as well as SJRMC, respectively) 
concerned. Anonymity of patients and confidentiality of data was preserved. 
Patients were informed of the purpose of the study and about the principles of 
voluntary and anonymous participation. Patients who returned their 
questionnaires were deemed to have given voluntary consent. 
The target populations were HD patients with Type 2 DM (Group 1) at one 
out-patient dialYSis center at S ..IRMC and non-dialysis patients with Type 2 DM 
(Group 2) at one family medicine clinic at SJRMC. The pilot study participants 
consisted of a sample of 20 HD patients with Type 2 DM from a cohort of 120 HD 
patients (with or without Type 2 DM). This sample size was based on the 
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statistic that 44% of ESRO patients will have OM. In addition, 20 non-dialysis 
patients with Type 2 OM from the family medicine clinic were obtained. The two 
(2) groups were matched based on age and gender. The dissertation study 
participants (N = 101) consisted of 51 HO patients with Type 2 OM and 50 non­
dialysis patients with Type 2 OM from the same locations as the pilot study, 
stated above. 
Inclusion criteria. Participants were HO or non-dialysis patients with Type 
2 OM who: 1) were under a physician's care; 2) were between the ages of 18 
and 85; and 3) had no previous history of renal replacement therapy (Timmers, 
et. aI., 2008). 
Exclusion criteria. Participants (HO or non-dialysis) patients with Type 2 
OM} who: 1} were under 18 years of age or older than 85 years of age; and 2) 
had previous history of renal replacement therapy. 
Study Site 
The setting of the study was one out-patient dialysis center located at 
SJRMC at 703 Main Street, Paterson, New Jersey, 07503 (northeastern NJ) and 
one family medicine clinic located at SJRMC. st. Joseph's Regional Medical 
Center is a tertiary care teaching hospital in an urban community. The institution 
represents one of several affiliated facilities within the St. Joseph's Healthcare 
System (including another acute-care facility, a long-term care facility, and 
children's hospital). The out-patient dialysis center had a capacity of 60 HO 
patients per shift (3 shifts per day; 6 days per week; therefore, 360 HO 
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treatments per week). All records were obtained from dialysis patients at 
SJRMC. 
Procedure 
Figure 3 provides the schematics of the procedures involved in this 
dissertation study. Approval to conduct research was obtained from the 
Nephrology Council of the participating institution. Upon approval, access to 
participants was done in collaboration with the Directors of Nephrology, Family 
Medicine & Research of the participating institution. Potential participants {HD 
patients with Type 2 DM (Group 1) and non-dialysis patients with Type 2 DM 
(Group 2)} were identified by designated administrative personnel of the 
institution. All participants were recruited through a solicitation letter (Appendix 
A). This letter included an explanation of the purpose of the research study, an 
indication that participation is voluntary, and that confidentiality and participant 
anonymity will be maintained throughout the study. This letter was stapled on 
the research packet. The packet contained the survey questionnaires, the IRB 
approved informed consent (Appendix B), and a return envelope. An additional 
copy of the informed consent (Appendix B) was provided in the packet for 
participants own records. The packet was given to each participant during their 
normally scheduled HD treatment or family medicine clinic visit by designated 
administrative personnel. Eligibility was determined by the completion of 3 
questions in the solicitation letter (Appendix A) including: 1) Are you between the 
ages of 18 and 85?; 2) Do you have Type 2 Diabetes Mellitus?; and 3) Do you 
have NO history of renal replacement therapy? If the participants met the 
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eligibility criteria they were requested to complete the Brief IPO (Appendix C) 
(Broadbent, et. aI., 2005) (to collect illness perceptions data), the DES-SF 
(Appendix D) (Anderson, et. aI., 2000; Tsay & Hung, 2004) (to collect 
empowerment data), and the GIF (Appendix E) (to collect sociodemographic 
information data). See Table 4. 
The PI chose to use the short forms because of their good validity and 
reliability, especially because they were used in combination - given the rapid 
assessment format. 
Spanish translation. As per SHU IRB's policies and procedures, the Letter 
of Solicitation and Informed Consent documents were submitted in both English 
and Spanish. A statement of certification as to the accuracy of the translation 
from an authorized company (ASTA-USA) on their letterhead stationary 
accompanied all such documents. English and Spanish versions (Certification of 
Spanish Translation - Appendix I) of each instrument were provided to each 
participant within the research packets. The collection of all data was a one-time 
5 Brief flfness Perception Questionnaire (Brief IPQ) (Spanish version). The Brief IPQ has been 
translated into 22 different languages including Spanish. A special acknowledgement to Eliana 
Guic from Universidad Cat6lica de Chile will be applied to all submissions and publications as her 
translation of the Brief IPQ into Spanish is copyrighted. The PI corresponded with the original 
author, Liz Broadbent and on December 6,2009 received written permission via e-mail to use 
both the English and Spanish versions of the Brief IPQ. The accuracy of the Spanish translation 
of the Brief IPQ was explored by Pacheco, e1. al. (2007). The aforementioned researchers 
designed the methodology in two (2) phases: 1) transcultural adaptation of the Brief IPQ 
(Spanish version) including: a) double translation; b) pilot; c} double back translation; and d) 
consensus and discussion with the team; and 2} cross-sectional study and assessment of 
psychometric characteristics. The researchers compared results (Spanish version) with original 
validation studies (English version). Statistical analyses included the following: 1) descriptive 
and response process analyses - out of 579 participants, 53% were women, with a mean age 
(SO) of 59.2; 2) reliability (Cronbach's coefficient alpha) at 0.668; 3) test-retest in a subgroup; and 
4) validity (Principal Component Analysis - Varimax) 2 components (emotional/inside and 
cognitive/outside) explain 57.3% of variance. The researchers concluded that the Brief IPQ 
(Spanish version) is a "structurally valid and reliable instrument to identify peoples' perceptions 
and develop interventions that take in account cognitive representations and emotional responses 
to chronic diseases that can facilitate to develop a shared decision making." 
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collection that took approximately 45 minutes. Any questions the participants 
may have had was encouraged and promptly answered by the designated 
administrative personnel. Please note participants were able to stop offering 
The Brief IPQ (Spanish version) is often used in the field. For example, in one study conducted 
by Mann, et. al. (2008), titled, "Misconceptions about diabetes and its management among low­
income minorities with diabetes", the researchers findings demonstrated that among the 151 
study participants {which were predominately Latino/a (58%) and African American (34%), with 
low income (89% <$30,000 per year)} despite having longstanding disease and regular outpatient 
diabetes care, participants frequently hold disease and medication beliefs that are inconsistent 
with a chronic disease model of diabetes. Using both the English and Spanish version of the 
Brief IPQ, all English- or Spanish- speaking adults with type 2 diabetes mellitus (DM) were 
eligible and able to self-report using the validated tools (Broadbent, et. aI., 2006). 
Diabetes Empowerment Scale - Short Form (DES-SF) (Spanish version). The DES-SF has been 
translated into Spanish by the Michigan Diabetes Research and Training Center (MDRTC) 
(2000). The MDRTC has developed several survey instruments for diabetes patients and health 
professionals including the Spanish version of the DES-SF. By downloading the forms, the 
researcher agrees to acknowledge the MDRTC as the source of the items in the survey 
instruments in any written instruments, reports, or publications resulting from their use or 
reproduction as per MDRTC's website at http://www.med.umich.edu/mdrtc/profs/survey.html. 
The accuracy of the Spanish translation of the instrument was confirmed in north Texas by 
Melancon, et. al. in 2009 when the researchers administered the survey to 82 participants in the 
north Texas region to measure self-efficacy (versus northern region of United States where the 
original Spanish version of the instrument was developed). To increase the accuracy of 
responses, questionnaires were provided in English and Spanish to all participants in a dual­
language format (English and Spanish) by the original author (MDRTC, 2000). However, the 
original instrument was developed in the northern region of the United States (Michigan). To 
ensure the dialect was similar to that used by the populations of north Texas, back translation 
was completed by a bi-lingual, Mexican-American Assistant at the local university located in north 
Texas. The new version was also reviewed for accuracy by the lead facilitator at a church 
located in north Texas. Data was coded using the scoring guidelines provided by the original 
author (MDRTC, 2000). Based on suggestions from a member of the research team, who is also 
a native of Mexico and a trained linguist and instructor of ESL, the instrument was adapted from a 
5-point to a 4-point Likert scale. The translator suggested the removal of phrase, "strongly 
disagree," as it was not culturally meaningful for this population in north Texas. To clarify 
answers, the term 'disagree' was used exclusively. Following this change, the modified 
instrument was pre-tested with a sample of six (6) participants in the community. Results from 
the pre-test demonstrated there were strong correlations between original and new format (r = 
0.85). The PI believes that given the proposed study location is in the northern United States 
(Paterson, NJ) similar to where the instrument was originally developed, the Spanish version 
provided by the original authors (MDRTC, 2000) is most appropriate and acceptable for use in the 
proposed sample population. 
The DES-SF (Spanish version) is often used in the field. For example, in one study conducted by 
Sarkar, Fisher, & Schillinger (2006), titled, "Is self-efficacy associated with diabetes self­
management across racelethnicity and health literacy?", the researchers found an association 
among the 413 participants (18% Asian/Pacific Islander; 25% African American; 42% Latino/a; 
and 15% white) and increasing self-efficacy score and self-management with regard to diet, 
exercise, self-monitoring blood glucose, and foot care. Using both the English and Spanish 
version of the DES-SF, all English- or Spanish- speaking adults with diabetes were eligible and 
able to self-report using the validated tools (Anderson, et. aI., 2000). 
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their illness perceptions and perceptions of empowerment responses at any time, 
without any questions or negative responses from the administrative personnel. 
All participants were asked to seal the completed questionnaire in the return 
envelope, and place the envelope in a designated drop box located on the out­
patient HD unit. The PI collected all research packets from the drop boxes 2 
weeks after distribution. 
The return of the completed questionnaires was considered consent from 
the study participants. All information in this study was kept strictly confidential. 
Data was entered into the GraphPad Prism (Version 5.0) statistical package 
(Graph Pad Corp., San Diego, CA) and SPSS (Version 18.0) (SPSS, Inc., 
Chicago, IL) and maintained on a USB memory drive. All research data was 
stored in locked file cabinet drawer on the out-patient HD unit. The PI and the 
three (3) members of her dissertation committee are the only individuals who had 
access to all of the research data for a period of three (3) years. All research 
data will be destroyed via professional shredding services after that time. 
Pilot study experience. The pilot study confirmed the methodology including 
procedures was sound. The logistics were worked out during the pilot phase. 
Ultimately, the pilot study served as the base foundation for the definitive study. 
Analytical Approaches 
The above pilot data collection was carried out over a 3-month period in 
2010; the above dissertation study data was carried out over 6-month period 
beginning in 2010 as well. Sociodemographic data including race or ethnicity 
(obtained by the GIF; Appendix E) was group-wise compared. Any 
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sociodemographic variables that were significantly different between the two 
groups were added, in a forward step-wise fashion, to the logistic regression 
model to account for confounding effects. 
In all tests, the level of statistical significance was set at a P value of < 
0.05 (two-tailed). Calculations were performed using GraphPad Prism (Version 
5.0) and SPSS (Version 18.0) on a personal computer platform. 
From the data obtained from the analyses, the PI was able to address the 
following research questions and hypotheses using the following analytical 
approaches: 
Research Question 1: Is there a difference in empowerment between HD 
patients with Type 2 DM (Group 1; case) and non-dialysis patients with Type 2 
DM (Group 2; control)? 
Hypothesis 1: There is a difference between empowerment between 
Groups 1 and 2. 
Analytical Approach 1: Global sum scores from the DES-SF were used to 
analyze outcomes associated with empowerment. Distribution was tested by 
D'Agostino-Pearson Omnibus normality test. For independently assorted 
samples, a t-test was used. If not normally distributed, Mann-Whitney U-test was 
used (Pearson, D'Agostino, & Bowman, 1977). 
Research Question 2: Is there a difference in illness perceptions between 
HD patients with Type 2 DM (Group 1; case) and non-dialysis patients with Type 
2 DM (Group 2; control)? 
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Hypothesis 2: There is a difference between illness perceptions between 
Groups 1 and 2. 
Analytical Approach 2: Global sum scores from the Brief-IPQ were used 
to analyze outcomes associated with perceptions of empowerment. Distribution 
was tested by D'Agostino-Pearson Omnibus normality test. For independently 
assorted samples, a t-test was used. If not normally distributed, Mann-Whitney 
U-test was used (Pearson, D'Agostino, & Bowman, 1977). 
Predictor variables were treated as continuous in that the ordinal data was 
compiled into an overall global score {for Brief IPQ (Appendix C) as well as the 
DES-SF (Appendix D)}. All continuous variables were tested for normality by the 
D'Agostino-Pearson Omnibus normality test (Pearson, D'Agostino, & Bowman, 
1977). 
Research Question 3: Is there an association between illness perceptions 
and empowerment in HD patients with Type 2 DM (Group 1)? 
Hypothesis 3: There is an association between illness perceptions and 
empowerment in Group 1. 
Analytical Approach 3: Correlation analysis was used. If normally 
distributed, Pearson's Product-Moment Correlation (PPM C) was used. If not 
normally distributed, Spearman's Rank Correlation Coefficient was used. 
Research Question 4: Is there an association between illness perceptions 
and empowerment in non-dialysis patients with Type 2 DM (Group 2)? 
Hypothesis 4: There is an association between illness perceptions and 
empowerment in Group 2. 
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Analytical Approach 4: Correlation analysis was used. If normally 
distributed, PPMC was used. If not normally distributed, Spearman's Rank 
Correlation Coefficient was used. 
Whenever the assumption of normality could be made (based on the 
results of the normality tests), parametric methods was used, i.e., for group-wise 
comparison t-tests were used and for correlations, Pearson's Product-Moment 
method was used. In the event that the results of normality tests suggested the 
use of non-parametric statistics, the Mann-Whitney U-test was substituted for t­
tests. 
Research Question 5: Is there a difference in association between illness 
perceptions and empowerment in patients with Type 2 DM who are receiving HD 
treatment (Group 1) and non-dialysis patients (Group 2) who are not? 
Hypothesis 5: There is a difference in association between illness 
perceptions and empowerment in Groups 1 and 2. 
Analytical Approach 5: A regression analysis was used. ANCOVA was 
used to determine Y slope and intercept. Details: on two lines, one representing 
the association between illness perceptions and perceptions of empowerment for 
HD patients with Type 2 DM (Group 1) and another for the association between 
illness perceptions and perceptions of empowerment for non-dialysis patients 
with Type 2 DM (Group 2). Both lines are plotted on a graph where there is one 
independent variable, illness perceptions (plotted on the X-axis) and one 
dependent variable, empowerment, on the Y-axis. Each line is the ordinary least 
squares (OLS) best-fit model for the association between the two variables for 
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each of the two groups. Using this method it is simple to examine the 
dispersion within the lines {using the 95% confidence bands (95% CB) to do this 
(Hayter, et. aI., 2007)} and the dispersion between the lines (ANOVA). However, 
since the dispersion is on a "slant", that being the slope of the OlS model 
represented by the regression lines, it is suggested as another way to think about 
ANCOVA - a 2-way ANOVA where independent variable is group assignment 
and the other variable is the regression line. 
In all tests, the level of statistical significance was set at a P value of < 
0.05 (two-tailed). Calculations were performed using GraphPad Prism (Version 
5.0) and SPSS (Version 18.0) on a personal computer platform. 
Calculation of sample size. Calculation of sample size for this dissertation 
study was based on results from the aforementioned exploratory pilot study 
conducted by the same PI (based on illness perceptions means and pools 
standard deviations; Timmers, et. aI., 2008), using G-power (Erdfelder, Faul, & 
Buchner, 1996) (t-test; n - 40); because it was powered, even a negative result 
was meaningful. All research questions were tested at two-sided alpha = 0.05; 
acceptable Beta was less than or equal to 0.20 (Power =80%). The number of 
participants to be included was increased by 15% (n - 46) based on the 
Asymptotic Relative Efficiency (ARE) (Randles & Wolf, 1979) for non-parametric 
analysis and use of the Mann-Whitney U-test. In other words, the ARE allowed 
the PI to go from a parametric analysis (Hest) to a non-parametric statistic 
(Mann-Whitney U-test). In terms of number of participant needs (vs. t-test), the 
Mann-Whitney U-test never can be more than a 15% difference. Expecting as 
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much as a 25% dropout rate (or "no response"), 58 participants per group were 
needed in the sample population. Clearly, the PI reached the appropriate pre­
determined sample size (based on the pilot study findings) for this dissertation 
study given a cohort (N = 101) of 51 HO patients with Type 2 OM (Group 1; case) 
and 50 non-dialysis patients with Type 2 OM (Group 2; control) (for a total of 101 
participants) was achieved. 
Ultimately, what the PI hoped to find was an association with illness 
perceptions and perceptions of empowerment in HO patients with Type 2 OM ­
so that in future works this dissertation study may lay the foundation and provide 
insight. 
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Chapter IV 

RESULTS 

The purposes of this dissertation study were: 1) to examine if there is an 
association between illness perceptions and perceptions of empowerment in HO 
patients with Type 2 OM; and 2) to investigate what differences in illness 
perceptions and perceptions of empowerment exist between HO patients with 
Type 2 OM and non-dialysis patients with Type 2 OM. In this prospective, cohort­
nested, case-control study (by nature, it is a quantitative one) (N =101), 51 HO 
patients with Type 2 OM (Group 1; case) and 50 non-dialysis patients with Type 
2 OM (Group 2; control) were developed. In all tests, the level of statistical 
significance was set at a P value of < 0.05 (two-tailed). Calculations were 
performed using GraphPad Prism (Version 5.0) and SPSS (Version 18.0) on a 
personal computer platform. This dissertation study findings were supported by 
the pilot study. 
Description of Sample Findings 
The baseline characteristics of participants in each group are presented 
in Table 3. Similarities and differences in demographics of participants were 
reviewed based on findings via General Information Form (GIF) data for both 
groups. All baseline characteristics were equivalent except for 3 of the 7. These 
3 (age, gender, and years of basic schooling) will later be examined as potential 
confounders. The data indicated homogeneity {respectively, (languages, P 
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Value =0.230); (ethnicity/race, P Value =0.148); and (employment status, P 
Value = 0.068)} and non-homogeneity {respectively, (median age, P Value = 
0.0004); (gender, P Value = 0.046); and (years of basic schooling, P Value = 
0.013)} of participants across the groups. Any differences that were less than or 
equal to P Value = 0.05 (respectively, age, gender, and years of basic schooling) 
were included in a logistic regression model to determine adjusted odds ratio. 
From the data obtained from the analyses, the PI was able to address the 
following research questions and hypotheses using the following analytical 
approaches: 
Description of Research Question 1 Findings. 
Research Question 1: Is there a difference in empowerment between HD 
patients with Type 2 DM (Group 1; case) and non-dialysis patients with Type 2 
DM (Group 2; control)? 
Hypothesis 1: There is a difference between empowerment between 
Groups 1 and 2. 
Analytical Approach 1: Global sum scores from the DES-SF were used to 
analyze outcomes associated with empowerment. Distribution was tested by 
D'Agostino-Pearson Omnibus normality test. For independently assorted 
samples, a t-test was used. Individual values of data are ordinal; however, global 
sum scores are interval. Non-parametric analyses are used for ordinal data or 
non-normally distributed data. The PI used the Mann-Whitney U-test because 
the data was not normally distributed (Pearson, D'Agostino, &Bowman, 1977). 
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Figure 5 illustrates the spread of DES-SF total scores is consistent 
between both groups (P Value =0.722). It makes sense that the spread of DES­
SF total scores is consistent between both groups because both groups have 
Type 2 OM. Similarities between the 2 groups may include the following: 1) 
managing the psychological aspects of OM; 2) assessing dissatisfaction and 
readiness to change; and 3) setting and achieving goals. 
Research Question 1 Finding: There is no difference between 
empowerment between Groups 1 and 2. This dissertation finding is consistent 
with the pilot study finding (pilot; P Value = 0.969). 
Description of Diabetes Empowerment Scale - Short Form 
(DES-SF) Findings. 
Description of Research Question 2 Findings. 
Research Question 2 had the same set up as Research Question 1; 
however, the other parameter, illness perceptions, was examined. 
Research Question 2: Is there a difference in illness perceptions between 
HD patients with Type 2 OM (Group 1; case) and non-dialysis patients with Type 
2 OM (Group 2; control)? 
Hypothesis 2: There is a difference between illness perceptions between 
Groups 1 and 2. 
Analytical Approach 2: Global sum scores from the Brief-IPQ were used 
to analyze outcomes associated with perceptions of empowerment. Distribution 
was tested by D'Agostino-Pearson Omnibus normality test. For independently 
assorted samples, a t-test was used. Individual values of data are ordinal; 
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however, global sum scores are interval. Non-parametric analyses are used for 
ordinal data or non-normally distributed data. The data was not normally 
distributed, therefore, the Mann-Whitney U-test was used (Pearson, D'Agostino, 
& Bowman, 1977). 
Predictor variables were treated as continuous in that the ordinal data was 
compiled into an overall global score {for Brief IPQ (Appendix C) as well as the 
DES-SF (Appendix D)}. All continuous variables were tested for normality by the 
D'Agostino-Pearson Omnibus normality test (Pearson, D'Agostino, & Bowman, 
1977). 
The PI was able to take a look at the Brief-IPQ at the macroscopic level 
via the use of the global sum scores. However, the PI used the item scores of 
the Brief-IPQ (specifically, the 8 characteristics) to examine the phenomenon at 
the microscopic level. Figure 6 illustrates the compilation of Brief-IPQ item 
scores for both groups (P Value = 0.076). Looking at the Brief-IPQ total scores 
to see if there was a difference in illness perceptions between the 2 groups, the 
data did not quite achieve statistical significance based on the pilot study. As a 
reminder, the calculation of sample size was based on total scores of Brief-IPQ in 
the pilot study. The fact remains a larger sample might have rendered this 
statistically significant. A future study, perhaps including a multi-center approach 
may yield statistically significant results. 
Research Question 2 Finding: There is no difference between illness 
perceptions between Groups 1 and 2. This dissertation study finding is 
consistent with the pilot study finding as well (pilot; P Value = 0.081). 
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Characteristic findings of Brief-IPQ. No statistically significance was found 
of 5 (out of a possible 8) characteristics of the Brief-IPQ (including personal 
control, treatment control, identity, concern, and cOherence). 
There was no statistical significance between the 2 groups related to 
personal control when asked, "How much control do you feel you have over your 
illness?" Figure 7 (personal control scores) illustrates participants' perception of 
how much personal control over illness (P Value = 0.450); absolutely no control 
to extreme amount of control. 
There was no statistical significance between the 2 groups related to 
treatment control when asked, "How much do you think your treatment can help 
your illness?" Figure 8 (treatment control scores) illustrates participants' 
perceptions of how much treatment can help illness (P Value = 0.838); not at all 
to extremely helpful. 
There was no statistical significance between the 2 groups related to 
identity when asked, "How much do you experience symptoms from your 
illness?" Figure 9 (identity scores) illustrates participants' perceptions of how 
many illness symptoms experienced (P Value = 0.213); no symptoms at all to 
many severe symptoms. 
There was no statistical significance between the 2 groups related to 
concern when asked, "How concerned are you about your illness?" Figure 10 
(concern scores) illustrates participants' perceptions of concern about illness (P 
Value = 0.428); not at all concerned to extremely concerned. 
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There was no statistical significance between the 2 groups related to 
coherence when asked, "How well do you feel you understand your illness?" 
Figure 11 (coherence scores) illustrates participants' perception of how well 
illness is understood (P Value =0.368); don't understand at all to understand 
very clearly. 
The other 3 (out of a possible 8), which were statistically significant, 
characteristic findings of the Brief-IPQ included consequences, timeline, and 
emotional representation. These characteristics are shown as categorical data, 
which was derived from ordinal data using Receiver Operating Characteristic 
(ROC) curve analyses; ROC curve analyses determines a "cut-off' score that 
best separated the 2 groups (Barnabei, Marazia, & De Caterina, 2007). First, we 
will look at the 3 statistically significant characteristics, which were analyzed in an 
univariate fashion. Later, we will look at this in light of the affect of potential 
confounders amongst the baseline characteristics (specifically, age, gender, and 
years of basic schooling). 
There was statistical significance between the 2 groups related to 
consequences when asked, "How much does your illness affect your life?" 
Figure 12 (consequence scores) illustrates non-dialYSis participants perceived 
illness affects their lives more severely (vs. dialysis participants) (P Value = 
0.005), when analyzed in an univariate fashion (1 dependent variable, group; and 
1 independent variable, consequences scores); not severe to severe. Based on 
ROC curve analyses, a consequences score;;::6 = perception of life more 
severely affected; <6 =perception of life less severely affected. Later on, the PI 
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examines the affect of potential confounders amongst the baseline 
characteristics. 
There was statistical significance between the 2 groups related to timeline 
when asked, "How long do you think your illness will continue?" Also, an 
univariate analysis, Figure 13 (timeline scores) illustrates dialysis participants 
perceived illness will more likely last forever (vs. non-dialysis participants) (P 
Value =0.040); not forever to forever. Based on ROC curve analyses, a timeline 
score ~9 = perception of illness will most likely last forever; <9 = perception of 
illness will less likely last forever. 
There was statistical significance between the 2 groups related to 
emotional representation when asked, "How much does your illness affect you 
emotionally (for example, does it make you angry, scared, upset or depressed?)" 
Figure 14 (emotional representation scores) illustrates non-dialysis participants 
perception of emotion affecting their lives is greater (vs. dialysis participants) (P 
Value = 0.0002); not extreme to extreme. Based on ROC curve analyses, an 
emotional representation score ~4 = perception of emotions more extremely 
affected; <4 = perception of emotions less extremely affected. 
Multivariate analyses. It was necessary to adjust for potential 
confounders, specifically, age, gender, and years of basic schooling, using 
multivariate analyses, which was performed by logistic regression. Table 4, 
highlights the potential confounders, extracted from the baseline characteristics 
of the study groups (as previously seen within Table 3). 
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In all tests, the level of statistical significance was set at a P value of < 
0.05 (two-tailed). Calculations were performed using GraphPad Prism (Version 
5.0) and SPSS (Version 18.0) on a personal computer platform. 
Gender affects the significance of consequences. Table 5 presents 
consequences as adjusted for potential confounders. Unadjusted consequences 
(as a characteristic of the Brief-IPQ) had a statistically significant P Value = 
0.005. Using logistic regression, the odds ratio (OR) = 3.29 and the 95% 
confidence interval (95% CI) =1.45 to 7.47. Consequences, adjusted for age, 
had a significant P Value = 0.0004 (OR = 5.04; 95% CI = 2.05 to 12.40). 
Consequences, adjusted for gender, was not significant (P Value =0.712; OR = 
1.17; 95% CI = 0.51 to 2.67). Consequences, adjusted for years of basic 
schooling, was significant (P Value =0.023; OR = 2.62; 95% CI = 1.14 to 6.03). 
Gender affects the significance of consequences. Although non-dialysis 
participants perceived illness affects their lives more severely (vs. dialysis 
participants) (P Value =0.005) (as shown in Figure 12), Table 6 indicates that 
female dialysis patients, as a group, perceived illness affects their lives more 
severely (vs. male, non-dialysis; female, non-dialysis; and male, dialysis groups); 
13 out of 17 female dialysis participants (78%). Consequences is not a 
completely independent association - it depends on gender. Further exploration 
is needed in future studies. 
Age and gender affects the significance of timeline. Table 7 presents 
timeline as adjusted for potential confounders. Unadjusted timeline (as a 
characteristic of the Brief-IPQ) had a statistically significant P Value =0.040. 
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Using logistic regression, the OR =0.36 and the 95% CI =0.14 to 0.94. 
Timeline, adjusted for age, did not have a significant P Value = 0.095 (OR = 0.44; 
95% CI = 0.17 to 1.15). Timeline, adjusted for gender, was not significant (P 
Value = 0.138; OR = 0.49; 95% CI = 0.19 to 1.26). Timeline, adjusted for years 
of basic schooling, was significant (P Value = 0.023; OR =0.37; 95% CI =0.15 to 
0.87). Table 8 indicates 81 % (34 out of 42) dialysis patients, 56 years of age or 
older, perceived illness will more likely last forever (vs. non-dialysis, ~56 years of 
age; non-dialysis, <56 years of age; and dialysis, <56 years of age patients). 
Table 9 shows 79% of male dialysis patients (27 out of 34) perceived illness will 
more likely last forever (vs. male, non-dialysis; female, non-dialysis; and female, 
dialysis patients). Timeline is not a completely independent association - it 
depends on age and gender. Further exploration is needed in future studies. 
Through the use of multivariate analyses, the PI was able to confirm 
emotional representation is a significant characteristic finding and remains an 
independent variable - regardless of the 3 potential confounders (age, gender, 
and years of schooling, respectively). Table 10 presents emotional 
representation as adjusted for potential confounders. Unadjusted emotional 
representation (as a characteristic of the Brief-IPQ) had a statistically significant 
P Value = 0.0002. Using logistic regression, the OR = 6.52 and the 95% CI = 
2.36 to 17.99. Emotional representation, adjusted for age, was significant (P 
Value =0.011; OR =3.60; 95% CI =1.35 to 9.62). Emotional representation, 
adjusted for gender, was significant (P Value =0.022; OR =2.96; 95% CI = 1.17 
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to 7.48). Emotional representation, adjusted for years of basic schooling, was 
significant (P Value =0.0002; OR =7.0; 95% CI =2.55 to 19.28). 
Description of Brief Illness Perception Questionnaire (Brief-IPQ) Findings. 
In order to look at an association between illness perceptions in 2 different 
groups (respectively, HO patients with Type 2 OM; and non-dialysis patients with 
Type 2 OM), Research Question 3 and 4 must be addressed. 
Description of Research Question 3 Findings. 
Research Question 3: Is there an association between illness perceptions 
and empowerment in HO patients with Type 2 OM (Group 1)? 
Hypothesis 3: There is an association between illness perceptions and 
empowerment in Group 1. 
Analytical Approach 3: Correlation analysis was used. If the data was 
normally distributed, Pearson's Product-Moment Correlation (PPMC) would have 
been used, however, it was not normally distributed. Therefore, the Spearman's 
Rank Correlation Coefficient was used because the data was not normally 
distributed. In the event that the results of normality tests suggested the use of 
non-parametric statistics, the Mann-Whitney U-test was substituted for t-tests. 
Therefore, the Mann-Whitney U-test was used because the data was not 
normally distributed. 
Table 11 indicates a high negative association between illness 
perceptions and empowerment in HO patients with Type 2 OM (Group 1) 
(rs =-0.493; P Value =0.0007). 
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Research Question 3 Finding: There is a negative association between 
illness perceptions and empowerment in Group 1. As illness perceptions 
impairment improves, empowerment decreases. The more HO patients with 
Type 2 OM understood their illness, the less empowered they felt. This goes 
along with Timeline findings. 
Description of association between illness perceptions and empowerment 
in dialysis participants (DES-SF vs. Brief-IPQ). 
Description ofResearch Question 4 Findings. 
Research Question 4: Is there an association between illness perceptions 
and empowerment in non-dialysis patients with Type 2 OM (Group 2)? 
Hypothesis 4: There is an association between illness perceptions and 
empowerment in Group 2. 
Analytical Approach 4: Correlation analysis was used. If the data was 
normally distributed, the PPMC would have been used. However, the data was 
not normally distributed, therefore, the Spearman's Rank Correlation Coefficient 
was used. In the event that the results of normality tests suggested the use of 
non-parametric statistics, the Mann-Whitney U-test was substituted for t-tests. 
Therefore, the Mann-Whitney U-test was used because the data was not 
normally distributed. 
Table 11 indicates no association was found between illness perceptions 
and empowerment in the non-dialysis group (rs =-0.233; P Value =0.108). 
Research Question 4 Finding: There is no association between illness 
perceptions and empowerment in Group 2. 
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Description of association between illness perceptions and empowennent 
in non-dialysis participants (DES-SF vs. Brief-IPQ). 
Description of Research Question 5 Findings. 
This leads IJS to the 5th and final research question, with an inkling of how 
it tu rned out. 
Research Question 5: Is there a difference in association between illness 
perceptions and empowerment in patients with Type 2 DM who are receiving HD 
treatment (Group 1) and non-dialysis patients (Group 2) who are not? 
Hypothesis 5: There is a difference in association between illness 
perceptions and empowerment in Groups 1 and 2. 
Analytical Approach 5: The Analysis of Covariance (ANCOVA), based on 
linear regression, was used to determine Y slope and intercept. Details: on two 
lines, one, representing the association between illness perceptions and 
perceptions of empowerment for HD patients with Type 2 DM (Group 1), and 
another, for the association between illness perceptions and perceptions of 
empowerment for non-dialysis patients with Type 2 DM (Group 2). Both lines are 
plotted on a graph where there is one independent variable, empowerment, 
(plotted on the X-axis) and one dependent variable, illness perception, on the Y­
axis. Each line is the ordinary least squares (OLS) best-fit model for the 
association between the two variables for each of the two groups. Using this 
method it is simple to examine the dispersion within the lines {using the 95% 
confidence bands (95% CB) to do this (Hayter, et. aI., 2007)} and the dispersion 
between the lines (ANOVA). However, since the dispersion is on a "slant", that 
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being the slope of the OLS model represented by the regression lines, it is 
suggested as another way to think about ANCOVA - a 2-way ANOVA where 
independent variable is group assignment and the other variable is the 
regression line. 
Figure 15 compares dialysis vs. non-dialysis participant and whether there 
is an association between illness perceptions and empowerment. Figure 15 
illustrates there is an association between illness perceptions and empowerment 
in dialysis participants (P Value =0.004; ~ =0.179); also, it illustrates there is no 
association between illness perceptions and empowerment in non-dialysis 
participants (P Value =0.122; ~ =0.050). 
Results of ANCOVA are illustrated in Figure 16, whereas, there is an 
association between illness perceptions and empowerment in dialysis and non­
dialysis participants (DES-SF vs. Brief-IPQ) (Pslopes = 0.198; Pintercept = 0.017). 
Research Question 5 Finding: There is a difference in the association 
between illness perceptions and empowerment in Groups 1 and 2. 
Description ofassociation between illness perceptions and empowerment 
in dialysis and non-dialysis participants (DES-SF vs. Brief-IPQ). 
Summary of research question findings. The summary of the 5 research 
question findings are as follows: 1) There is no difference between 
empowerment between Groups 1 and 2; 2) There is no difference between 
illness perceptions between Groups 1 and 2; however, the PI found 3 statistically 
significant characteristics (specifically, consequences, timeline, and emotional 
representation) from the Brief-IPQ via univariate analyses; 3) There is a 
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negative association between illness perceptions and empowerment in 
Group 1; 4) There is no association between illness perceptions and 
empowerment in Group 2; and 5) There is an association between illness 
perceptions and empowerment in Groups 1 and 2. 
Summary of significant characteristic findings. Univariate analyses 
indicated differences between 3 characteristics of the Brief-IPQ. First, the non­
dialysis group perceived illness affects their lives more severely (consequences; 
P Value =0.005). However, via multivariate analyses, the PI discovered 78% of 
female dialysis patients perceived illness affects their lives more severely (vs. 
any other group). Secondly, the dialysis group perceived illness will more likely 
last forever (timeline; P Value = 0.040). However, via multivariate analyses, the 
PI discovered both age and gender affects the significance of timeline. Lastly, 
the non-dialysis groups perception of emotion affecting their lives is greater 
(emotional representation; P Value = 0.0002), which turned out to be insensitive 
to any of the 3 potential confounders (age, gender, and years of schooling, 
respectively) . 
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Chapter V 

DISCUSSION 

Theoretical Application 
There is an Association between Illness Perceptions and Perceptions of 
Empowerment 
Prior to the completion of this dissertation study, based on the literature, 
we knew that: 1) challenges may lead to a negative perception of illness; and 2) 
challenges may lead to a decrease in empowerment. Prior to this dissertation, 
what we did not know is whether there is an association between illness 
perceptions and empowerment. But, now we know there is. There is an 
association between illness perceptions and empowerment in non-dialysis and 
dialysis participants. 
It was important to examine this theoretical concept because if we could 
identify an association between illness perceptions and perceptions of 
empowerment - we could examine how to modify illness perceptions impairment 
(such as consequences, timeline, and emotional representations). Therefore, we 
are now able to indirectly address empowerment. We have been successful, 
through this work, at suggesting the associations to formulate practice application 
based on our theoretical framework. 
Let's revisit the Empowerment Theory and look at how it relates to these 
dissertation findings. Traditionally, the nephrology team (consisting of various 
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healthcare professionals including Registered Dietitians) focused educational 
efforts on providing patients with the knowledge needed to comply with the 
prescribed treatment regimen. However, studies have consistently indicated that 
patients cannot be forced to follow a lifestyle that is decided by others. 
Therefore, patient empowerment and self-management are crucial to ensure that 
patients know they are still in control of their lives and are motivated to become 
engaged partners with their nephrology healthcare team (McCarley, 2009). 
Patient education is an important component in the management of 
dialysis patients (Rantanen, et. aI., 2008; Klang, et. aI., 1998). Good quality 
patient education is based on patients' individual needs (Rantanen, et. aI., 2008; 
Leino-Kilpi & Vuorenheimo, 1994); therefore, it is important to focus educational 
efforts based on individual perceptions of empowerment. 
The empowerment approach suggests that patients have the capacity to 
make choices and be responsible for the consequences of their actions 
(Rantanen, et. aI., 2008; Curtin, Johnson, & Schatell, 2004; Feste & Anderson, 
1995). 
This dissertation study provides a better understanding of illness 
perceptions of HD patients with Type 2 DM and their association with perceptions 
of empowerment and how this association impacts QoL. Since, previously, there 
was not enough literature on this topic, the outcomes of this dissertation study, 
therefore, have provided a foundation for and insight regarding HD patients with 
Type 2 DM. 
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Findings from this dissertation study may positively impact educational 
threads by bringing attention to the need for nephrology healthcare providers to 
identify HO patients' (with Type 2 OM) illness perceptions and their association 
with perceptions of empowerment. By modifying illness perceptions 
impairments, empowerment can, therefore, be indirectly addressed. Educational 
interventions for this patient population may then be designed, specifically for 
identification and coping strategies, ultimately increasing QoL. Subsequently, 
this can provide a basis for developing interventions aimed at altering patients' 
illness perceptions to improve perceptions of empowerment. 
Implications for Practice 
Let's review some practical applications for these dissertation findings. 
The results of this dissertation study have important implications related to the 
attention that healthcare professionals pay to the perceptions of empowerment of 
HO patients with Type 2 OM. In addition, results are valuable in planning 
individualized patient education and can be used to increase the patient's input in 
the treatment planning phase. 
Consequences and patient education. Patient education is an important 
component in the management of dialysis patients (Rantanen, et. aI., 2008; 
Klang, et. aI., 1998). Good quality patient education is based on patients' 
individual needs (Rantanen, et. aI., 2008; Leino-Kilpi & Vuorenheimo, 1994); 
therefore, it is important to focus educational efforts based on individual 
perceptions of empowerment. The empowerment approach suggests that 
patients have the capacity to make choices and be responsible for the 
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consequences of their actions (Rantanen, et. aI., 2008; Curtin, Johnson, & 
Schatell, 2004; Feste & Anderson, 1995). 
Non-dialysis participants perceived illness affects their lives more severely 
(vs. dialysis participants) (P Value = 0.005) as illustrated in Figure 12 
(consequences scores). Diabetes care is not only to maintain stable levels of 
blood sugar, but also to avoid the consequences it may bring to the various body 
systems (NKF, 2011). Patient education for those with Type 2 OM within a clinic 
setting may focus on the following topics: 1) diabetic neuropathy (decreased 
limb sensitivity, ulcers, reduced blood supply, amputation); 2) heart disease 
(altered levels of sugar in blood, heart works beyond capacity, weakened heart 
muscle); 3) renal failure (damage to the filter system of the kidneys); and 4) 
diabetic retinopathy (damage to retina because of circulatory failure, macular 
degeneration, blindness). Providing patient education regarding how to prevent 
consequences, via the empowerment approach, may reduce non-dialysis 
participants' perception that illness affects their lives more severely. As 
determined via multivariate analyses, consequences is not a completely 
independent association - it depends on gender, specifically females. Further 
exploration is needed in future studies. 
Timeline and racial disparity awareness. Dialysis participants perceived 
illness will more likely last forever (vs. non-dialysis participants) (P Value =0.040) 
as illustrated in Figure 9 (timeline scores). In one study titled, "Why don't more 
African-Americans on dialysis get transplants?", over 600 patients and 278 
nephrologists by Harvard physician-investigators were surveyed in 2004. It is 
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well-known that blacks are less likely to get renal transplants than whites (QI, 
2011). This is found to be true - even when they are eligible, and insurance 
status, as well as other illnesses, are controlled for. The survey results 
suggested that nephrologists were less likely to believe that transplantation 
improves survival for blacks than whites (69% vs. 81 %). Blacks were less likely 
than whites to report receiving some or a lot of information about transplantation 
(55% vs. 74%). Raising awareness of patients' eligibility to receive renal 
transplants may empower dialysis participants who perceive illness will more 
likely last forever. Timeline is not a completely independent association - it 
depends on age and gender, specifically male patients, 56 years of age and 
older. Further exploration is needed in future studies. 
Emotional representation and mental health management. Non-dialysis 
participants perception of emotion affecting their lives is greater (vs. dialysis 
participants) (P Value = 0.0002) as illustrated in Figure 14 (emotional 
representation scores). Greater emotional representation of OM is associated 
with poorer self-care and impaired metabolic control. Adults with OM are twice 
as likely to be depressed than similar individuals without OM; and depression is 
associated with poor glycemic control. Findings from a cross national survey 
revealed 41 % of people with OM had poor psychological well-being. According 
to Paddison, et. aI., 2010, the majority of healthcare professionals believe that 
psychological problems affect their patients' self-management behavior. 
Focusing on mental health management as a component within the multi­
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disciplinary approach in treating Type 2 DM may empower patients, thereby, 
reduce illness perceptions of emotion negatively affecting their lives. 
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Chapter VI 

SUMMARY AND CONCLUSION 

Limitations 
One limitation of this dissertation study included the use of a single-center 
for each group. The sample for this study was drawn from one out-patient 
dialysis center located at SJRMC at 703 Main Street, Paterson, New Jersey, 
07503 (northeastern NJ) and one family medicine clinic located at S ..IRMC. St. 
Joseph's Regional Medical Center is a tertiary care teaching hospital in an urban 
community. The institution represents one of several affiliated facilities within the 
St. Joseph's Healthcare System (including another acute-care facility, a long­
term care facility, and children's hospital). Perhaps future works could include a 
multiple-center approach model, thereby, increasing the likelihood of 
generalizability. 
By using the Brief-IPQ and the DES-SF, another limitation was self­
reporting, which has the potential to reflect inaccurate information, if the patient 
has difficulty understanding what is written, or cannot see or physically write out 
responses. However, the questionnaire can be used with an interpreter in future 
studies, if deemed necessary. 
The results are generalizable to primarily urban populations given the 
diversity of the sample patient population from SJRMC. 
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Conclusions 
In sum, the purposes of this dissertation study were: 1) to examine if there is 
an association between illness perceptions and perceptions of empowerment in 
HD patients with Type 2 DM; and 2) to investigate what differences in illness 
perceptions and perceptions of empowerment exist between HD patients with 
Type 2 DM and non-dialysis patients with Type 2 DM. So why was this study 
done? This study was done to add to the literature, knowledge concerning how 
to increase the QoL of dialysis patients with Type 2 DM. 
Findings from this dissertation study may positively impact educational 
threads by bringing attention to the need for nephrology healthcare providers 
(including Registered Dietitians) to identify HD patients' (with Type 2 DM) illness 
perceptions and their association with perceptions of empowerment. By 
modifying illness perceptions impairments, empowerment can, therefore, be 
indirectly addressed. Educational interventions for this patient population may 
then be designed, specifically for identification and coping strategies, ultimately 
increasing QoL. Subsequently, this can provide a basis for developing 
interventions aimed at altering patients' illness perceptions to improve 
perceptions of empowerment. 
We can address illness perceptions impairments through the empowerment 
approached, based on the empowerment theory, because we now know for sure 
there is an association. 
Regarding consequences, through the empowerment theory approach we 
now know to educate female non-dialysis patients with Type 2 DM regarding 
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health topics such as heart failure and diabetic retinopathy; ultimately, to 
increase their QoL. 
Pertaining to timeline, we now know to empower male dialysis patients with 
Type 2 DM, 56 years of age or older, with the knowledge they may be eligible for 
a renal transplant. 
Also, we now know this study supports focusing on mental health 
management of non-dialysis patients with Type 2 DM via the empowerment 
theory approach. 
A lot of future studies may be administered with this dissertation study serving 
as the foundation. 
- 76­
REFERENCES 

American Diabetes Association (ADA). (2001). Standard of medical care for 
patients with diabetes mellitus. Diabetes Care, 24, 33-43. 
Anderson, R, et. al. (1995). Patient empowerment. Diabetes Care, 18, 
943-949. 
Anderson, R., et. al. (2000). The diabetes empowerment scale. Diabetes Care, 
23, 111-119. 
Anderson, R, et. al. (2003). The diabetes empowerment scale - short form 
(DES-SF). Diabetes Care, 26,1641-1643. 
Barnabei, L., Marazia, S., & De Caterina, R (2007). Receiver operating 
characteristic (ROC) curves and the definition of threshold levels to diagnose 
coronary heart disease on electrocardiographic stress testing. Part I: the use 
of ROC curves in diagnostic medicine and electrocardiographic markers of 
ischaemia. Journal of Cardiovascular Medicine, 8, 873-881. 
Bodenheimer, T., et. al. (2002). Patient self-management of chronic disease in 
primary care. Journal of the American Medical Association, 288, 2469-2475. 
Broadbent, E., et. al. (2005). The brief illness perception questionnaire. Journal 
of Psychosomatic Research, 60,631-637. 
Brodin, E., et. al. (2001). Physical activity, muscle performance and quality of 
life in patients treated with chronic peritoneal dialysis. Scandinavian Journal 
of Urology & Nephrology, 35, 71-78. 
Byer, B. & Meyer, L. (2000). Psychological correlates of adherence to 
medication in asthma. Psychology, Health, Medicine 5, 389-393. 
Cameron, L. & Leventhal, H. (2003). Self-regulation, health, & illness: an 
overview. In L. Cameron & H. Leventhal (Eds.), The Self-Regulation of Health 
and Illness Behaviour. London: Routledge. 
Cleary, J. & Drennan, J. (2005). Quality of life of patients on haemodialysis for 
end-stage renal disease. Journal ofAdvanced Nursing, 51,577-586. 
Curtin, R, Johnson, H., & Schatell, D. (2004). The peritoneal dialysis 
experience: insights from long-term patients. Nephrology Nursing Journal, 
31,615-624. 
Curtin, R, et. al. (2002). Long-term dialysis survivors: a transformational 
experience. Qualitative Health Research, 12, 609-624. 
- 77­
Dagogo-Jack, S. (2002). Preventing diabetes related morbidity and mortality in 
the primary care setting. Journal of National Medical Association, 94, 
549-560. 
Davison, S. (2007). Chronic kidney disease. Geriatrics, 62, 17-23. 
Erdfelder, E., Faul, F., & Buchner, A. (1996). GPOWER: a general power 
analysis program. Behavior Research Methods, Instruments, & Computers, 
28,1-11. 
Faris, M. (1994). When your kidneys Fail (3rd Ed.). Los Angeles: 
National Kidney Foundation of Southern California. 
Feste, C. &Anderson, R. (1995). Empowerment: from philosophy to practice. 
Patient Education and Counseling, 26, 139-144. 
Fortune, D., et. al. (2002). Psychological stress, distress, and disability in 
patients with psoriasis: consensus and variation in the contribution of illness 
perceptions, coping and alexithymia. British Journal of Clinical Psychology, 
41,157-174. 
Fowler, C. &Baas, L. (2006). Illness representations in patients with chronic 
kidney disease on maintenance hemodialysis. Nephrology Nursing Journal, 
33, 173-187. 
Funnel, M. & Weiss, M. (2009). Empowering patients with diabetes. Nursing, 9, 
34. 
George, J., et. aI., (2008). Clinical effectiveness of a brief educational 
intervention in type 1 diabetes: results from the BITES (Brief Intervention in 
Type 1 diabetes, Education for Self-efficacy) trial. Diabetic Medicine, 25 
1447-1453. 
Glascoe, M. (2009). Paterson public schools public report. New Jersey 
Department ofEducation. Retrieved on August 30, 2009 from the 
World Wide Web: 
http://www.nj.gov/education/abbotts/sosd/annreptJpaterson.pdf 
Glasgow, R., Toobert, D., & Gillette, C. (2001). Psychosocial barriers to 
diabetes self-management and quality of life. Diabetes Spectrum, 14, 33-41. 
Griva, K., Myers, L., &Newman, S. (2000). Illness perceptions and self efficacy 
beliefs in adolescents and young adults with insulin dependent diabetes 
mellitus. Psychology and Health, 15, 733-750. 
-78 ­
Hagren, B., et. aI., (2005). Maintenance haemodialysis: patients' experiences 
of their life situation. Journal ofClinical Nursing, 14,294-300. 
Hale, E., Treharne, & Kitas, G. (2007). The common-sense model of self­
regulation of health and illness: how can we use it to understand and respond 
to our patients' needs? Rheumatology, 46, 904-906. 
Hayter A., et. al. (2007). Journal ofStatistical Planning and Inference, 137: 
1213-1225. 
Harwood, L. & Wilson, B. (2008). Physiological and psychosocial stressors and 
coping in individuals with chronic kidney disease. Nephrology Nursing 
Journal, 35, 176. 
Helder, D., et. al. (2002). Living with Huntington's disease: illness 21 
perceptions, coping mechanism, and patient's well-being. British Journal of 
Health Psychology, 7, 449-462. 
Helder, D., et. al. (2002). Living with Huntington's disease: illness 
perceptions, coping mechanisms, and spouses' quality of life. International 
Journal ofBehavioral Medicine 9,37-52. 
Herbert, R, et. al. (2009). A systematic review of questionnaires measuring 
health-related empowerment. Research & Theory for Nursing Practice: An 
International Journal, 23, 107-132. 
Horne, R. (2003). Treatment perceptions and self-regulation. In L. Cameron & 
H. Leventhal (Eds.), The Self-Regulation ofHealth and Illness Behaviour. 
London: Routledge. 
Horne, R. & Weinman, J. (1999). Patients' beliefs about prescribed medicine 
and their role in adherence to treatment in chronic physical illness. Journal of 
Psychosomatic Research, 47, 555-567. 
Horne, R & Weinman, J. (2002). Self-regulation and self-management in 
asthma: exploring the role of illness perceptions and treatment beliefs in 
explaining non-adherence to preventer medication. Psychology and Health, 
17, 17-32. 
lliescu, E., et. al. (2003). Quality of sleep and health-related quality of life in 
haemodialysis patients. Nephrology Dialysis Transplantation, 18,126-132. 
Jayne, R & Rankin, S. (2001). Application of Leventhal's self-regulation model 
to Chinese immigrants with type 2 diabetes. Journal ofNursing Scholarship, 
33,53-59. 
- 79­
Klang, B., et. al. (1998). Predialysis patient education: effects on functioning 
and well-being in uraemic patients. Journal ofAdvanced Nursing, 28, 36-44. 
Leino-Kilpi, H. & Vuorenheimo, J. (1994). The patients' perspective on nursing 
quality: developing framework for evaluation. Quality Assurance in Health 
Care, 6, 1-11. 
Leventhal, H., Brissette, I., & Leventhal, E. (1992). Illness cognition: using 
common sense to understand treatment adherence and affect cognition 
interactions. Cognitive Therapy and Research, 16, 143-163. 
Leventhal, H., Nerenz, D., & Steele, D. (1984). Illness representation and 
coping with health threat. In A. Baum, S.E. Taylor, & J.E. Singer (Eds.) 
Handbook of Psychology and Health. Hillsdale: Erlbaum. 
Lindqvist, R., Carlsson, M. & Sjoden, P. (1998). Coping strategies and quality of 
life among patients on hemodialysis and continuous ambulatory peritoneal 
dialysis. Scandinavian Journal of Caring Sciences, 12, 223-230. 
Little, P., et. al. (2004). Randomised controlled trial of effect of leaflets to 
empower patients in consultations in primary care. British Medical Journal, 
328,441-444. 
Llewellyn, C., et. al. (2003). The illness perceptions and treatment beliefs of 
individuals with severe hemophilia and their role in adherence to home 
treatment. Psychology and Health, 18, 185-200. 
Logan, S., Pelletier, M. & Hodgins, M. (2006). Stressors and coping of in­
hospital haemodialysis patients aged 65 years and over. Journal ofAdvanced 
Nursing, 56, 382-391. 
Lucas, G., et. al. (2008). Chronic kidney disease incidence, and progression to 
end-stage renal disease, in HIV infected individuals: a tale of two races. 
Journal oflnfectious Diseases, 197, 1548-1557. 
McCarley, P. (2009). Patient empowerment and motivational interviewing: 
engaging patients to self-manage their own care. Nephrology Nursing 
Journal, 36,409-413. 
Morsch, C., Goncalves, L. & Barros, E. (2006). Health-related quality of life 
among haemodialysis patients - relationship with clinical indicators, morbidity 
and mortality. Journal of Clinical Nursing, 15, 498-504. 
Moss-Morris, R., et. al. (2002). The revised illness perception questionnaire 
(IPQ-R). Psychology and Health, 17, 1-16. 
- 80­
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP). (2009). Retrieved on October 7,2009 from the World Wide 
Web: http://www.cdc.gov/diabetes 
National Kidney Disease Education Program (NKDEP). (2008). Retrieved on 
September 19,2008 from the World Wide Web: http://www.nkdep.nih.gov/ 
National Kidney Foundation (NKF). (2011). Retrieved on 
September 24,2011 from the World Wide Web: http://www.kidney.org/ 
Norris, S., et. al. (2002). Self-management education for adults with type 2 
diabetes. Diabetes Care, 25, 1159-1171. 
Paddison, C., et. al. (2011). Predictors of anxiety and depression among people 
attending diabetes screening: a prospective cohort study embedded in the 
ADDITION (Cambridge) randomized control trial. British Journal of Health 
Psychology, 16,213-226. 
Parmer, M. (2002). Chronic renal disease. British Medical Journal, 325, 85-90. 
Powers, P. (2003). Empowerment as treatment and the role of health 
professionals. ANS, 26, 227-237. 
Quality Interactions (QI). (2011). Retrieved on 
September 24, 2011 from the World Wide Web: 
http://www.gualityinteractions.org/ 
Rantanen, M., et. al. (2008). Knowledge expectations of patients. Nephrology 
Nursing Journal, 35, 249-255. 
Rees, G., et. al. (2004). Illness perceptions and distress in woman increased 
risk of breast cancer. Psychology and Health, 19,749-765. 
Ruben, R., Peyrot, M., & Saudek, C. (1991). Differential effect of diabetes on 
self-regulation and life-style behaviors. Diabetes Care, 14, 335-338. 
Ruggenenti, P., Schieppati, A. & Remuzzi, G. (2001). Progression, remission, 
regression of chronic renal diseases. Lancet, 357, 1601. 
Rutter, C., & Rutter, D. (2002). Illness representation, coping and outcome in 
irritable bowel syndrome (IBS). British Journal of Health Psychology, 7, 
377-391. 
- 81 ­
Sakkas, G., et. al. (2008). Intradialytic aerobic exercise training ameliorates 
symptoms of restless legs syndrome and improves functional capacity in 
patients on hemodialysis: a pilot study. American Society ofArlificiallnternal 
Organs, 54,185-190. 
Schatell, D., & Witten, B. (2005). Dialysis patient empowerment: what, why and 
how. Nephrology News & Issues, 19,37-44. 
Searle A. & Murphy S. (2000). Representations of illness: their relationship with 
an understanding of and adherence to homoeopathic treatment. Psychology, 
Health, & Medicine, 5, 179-191. 
Simmons, D. (2001). Personal barriers to diabetes care: is it me, them, or us? 
Diabetes Spectrum, 14, 10-12. 
Smith, J. & Tolson, J. (2008). Recognition, diagnosis, and treatment of restless 
legs syndrome. Journal of the American Academy of Nurse Practitioners, 20, 
396-401. 
The Diabetes Control and Complication Trial Research Group. (1993). The 
effect of an intensive treatment of diabetes on the development and 
progression of long-term complications in insulin dependent diabetes mellitus. 
New England Journal of Medicine, 329, 977-986. 
Timmers, L., et. al. (2008). Illness perceptions in dialysis patients and their 
association with quality of life. Psychology & Health, 23, 679-690. 
Tims, S., Kling, L., & Bennett, P. (2007). Empowerment for people with end 
stage renal disease: a literature review. Renal Society of Australasia Journal, 
3,52-58. 
Tsay, S., & Hung, L. (2004). Empowerment of patients with end-stage renal 
disease - a randomized controlled trial. International Journal of Nursing 
Studies, 41, 59-65. 
Tyrell, J., et. al. (2005). Older patients undergoing dialysis treatment: cognitive 
functioning, depressive mood and health-related quality of life. Aging & 
Mental Health, 9, 374-379. 
United Kingdom Prospective Study Group. (1998). Intensive blood-glucose 
control with sulphonylureas or insulin compared with conventional treatment 
and risk of complications in patients with type 2 diabetes. Lancet, 352, 
837-853. 
- 82­
U.S. Renal Data System (USRDS). (2009). 	USRDS 2009 Annual Data Report: 
Atlas ofEnd Stage Renal Disease in the United States. Retrieved on 
October 7,2009 from the World Wide Web: http://www.usrds.org/adr.htm 
Weinman, J., et. al. (1996). The illness perception questionnaire: a new method 
for assessing the cognitive representation of illness. Psychology and Health, 
11, 431-341. 
Whitmarsh, A., Koutantji, M., & Sidell, K. (2003). Illness perceptions, mood, and 
coping in predicting attendance at cardiac rehabilitation. British Journal of 
Health Psychology, 8, 209-221 . 
Yung, J. (2008). Optimal ultrafiltration profiling in hemodialysis. Nephrology 
Nursing Journal, 35, 287-289. 
- 83 ­
Figure 1. 
The Common Sense Model (CSM). 
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Figure 2. 
The 5 domains of the Common Sense Model (CSM). 
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Figure 3. 
Schematics of theoretical framework for dissertation study: 
illness perceptions and empowerment may influence one another. 
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Schematics of theoretical framework for dissertation study: 
illness perceptions and empowerment may influence one another. 
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Figure 4. 
Schematics of dissertation study procedures. 
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Schematics of dissertation study procedures. 
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Figure 5. 
The spread of DES-SF total scores is consistent between both groups. 
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Figure 6. 
The compilation of Brief-IPQ item scores for both groups. 
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Figure 7. 
Participants' perceptions of how much personal control over illness. 
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Figure 8. 
Participants' perceptions of how much treatment can help illness. 
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Figure 9. 
Participants' perceptions of how many illness symptoms experienced. 
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Figure 10. 
Participants' perceptions of concern about illness. 
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Figure 11. 
Participant's perceptions of how well illness is understood. 
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Figure 12. 
Non-dialysis participants perceived illness affects their lives more 
severely (vs. dialysis participants). 
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Figure 13. 
Dialysis participants perceived illness will more likely last forever 
(vs. non-dialysis participants). 
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Figure 14. 
Non-dialysis participants perception of emotion 
affecting their lives is greater (vs. dialysis participants). 
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Figure 15. 

DES-SF vs. Brief-IPQ: dialysis participants.; 

DES-SF vs. Brief-IPQ: non-dialysis participants. 
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5 
Figure 16. 
DES-SF vs. Brief-IPQ: there is an association between 
Illness perceptions and empowerment in 
non-dialysis and dialysis participants. 
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Table 1. 
Comparative overview of the three (3) tools noted in the literature regarding 
illness perceptions. 
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Comparative overview of the three (3) tools noted in the literature regarding 
illness perceptions. 
Utilization & 
Adaptability 
Revised ­
More 
Accurate to 
CSM 
Rapid 
Assessment 
Format 
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Table 2. 
Comparative overview of the two (2) tools noted in the literature regarding 
empowerment. 
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Comparative overview of the two (2) tools noted in the literature regarding 
empowerment. 
Utilization & 
Adaptability 
Rapid 
Assessment 
Format 
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Table 3. 
Baseline characteristics of study groups (N = 101). 
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Baseline characteristics of study groups (N =101). 
Age (years) 55.0 (47.3 to 62.8) 0.0004 
{median, (lQR)} 
Gender 23/27 34/17 0.046 
(Male/Female) 
Time on HD (months) N/A 55.0 (36.0 to 72.0) N/A 
{median, (lQR)} Dr5 %Years 
Languages 
English 
Spanish 
Other 
31 
14 
5 
30 
19 
2 
0.230 
Ethnicity/Race 41/9 47/4 0.148 
(non-White/White) 
Years of Basic Schooling 38/12 26/25 0.013 
(~12/(12) 
Employment Status 
Emplayeed 
Retired 
10 
10 
1 
24 
0.068 
2S 8 
5 18 
GIF, General Information Form 
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Table 4. 
Potential confounders of study groups (N =101). 
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Potential confounders of study groups (N =101). 
Gender 
(Male/Female) 
Years of Basic Schooling 
(~12/<12) 
23/27 
38/12 
34/17 0.046 
26/25 0.013 
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Table 5. 
Consequences: adjustments for potential confounders. 
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Consequences: adjustments for potential confounders. 
PValue Odds Ratio 
0.005 3.29 
0.0004 5.04 2.05 to 12.40 
0.712 1.17 0.51 to 2.67 
Adjusted for 0.023 2.62 1.14 to 6.03 
Years of Basic Schooling 
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Table 6. 
Gender affects the significance of consequences. 
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Gender affects the significance of consequences. 
Non-Dialysis 
(n = 50) 
14/23 (61%) 
18/27 (67%) 13/17 (78%) 
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Table 7. 
Timeline: adjustments for potential confounders. 
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Timeline: adjustments for potential confounders. 
Odds Ratio 
0.36 
0.095 0.44 0.17 to 1.15 
0.138 0.49 0.19 to 1.26 
Adjusted for 0.023 0.37 0.15 to 0.87 
Years of Basic Schooling 
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Table 8. 
Age affects the significance of timeline. 
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Age affects the significance of timeline. 
15/26 (58%) 7/9 (78%) 
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Table 9. 
Gender affects the significance of timeline. 
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Gender affects the significance of timeline. 
Non-Dialysis 
(n =50) 
13/23 (57%) 
13/27 (48%) 13/17 (77%) 
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Table 10. 
Emotional representation: adjustments for potential confounders. 
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Emotional representation: adjustments for potential confounders. 
PValue Odds Ratio 
0.0002 6.52 
0.011 3.60 1.35 to 9.62 
0.022 2.96 1.17 to 7.48 
Adjusted for 0.0002 7.00 2.55 to 19.28 
Years of Basic Schooling 
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Table 11. 
Results of research question # 3 & #4. 
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Results of research question #3 & #4. 
Dialysis 
-0.493 -0.233 
0.0007 0.108 
High None 
Significance Negative 
Association 
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Appendix A 
Solicitation Letter 
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Solicitation Letter 
Dear Participant, 
My name is Jaime L. Pula, MS, RD, and I am a doctoral candidate at Seton Hall 
University's School of Health & Medical Sciences. I am conducting a research 
project titled, "Illness perceptions in hemodialysis (HO) patients with Type 2 
diabetes mellitus (OM) and their association with empowerment: a pilot study." 
This project will culminate in my dissertation. 
Please read the following pages of this Solicitation Letter to further explain the 
purposes of this study, expected duration of your participation, description of the 
procedures (including specific name and contents of all surveys), statement of 
the voluntary nature of your participation, statement of how anonymity will be 
preserved, and how your information will be securely stored to maintain 
confidentiality. 
I am inviting you to participate in this research study because you are a patient 
with Type 2 Diabetes Mellitus. 
Please begin by answering the following questions: Circle your responses. 
1. 	 Are you between the ages of 18 and 85? 

Yes No 

2. 	 Do you have Type 2 Diabetes Mellitus? 

Yes No 

3. 	 Do you have NO history of renal replacement therapy? 

Yes No 

If you have answered YES to ALL of the above questions you ARE ELIGIBLE 
for participation in this study, please open the research packet and begin 
completing the enclosed questionnaires. Place the completed questionnaire in 
the enclosed return envelope. Please seal the envelope and place in the 
designated drop box on the unit. 
If you answered NO to ANY of the above questions you are NOT ELIGIBLE to 
participate in this study. Thank you for your time and please return the research 
packet by placing it in the designated drop box on your unit. 
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Carta de 50licitaci6n 
Estimado participante: 
Mi nornbre es Jaime L. Pula, MS, RO, Yson un candidato a doctorado de la 
Facultad de Salud y Ciencias Medicas de la Universidad Seton Hall. Estoy 
lIevando a cabo un proyecto de investigacion que tiene el titulo de "Illness 
perceptions in hemodialysis (HO) patients with Type 2 diabetes mellitus (OM) 
and their association with empowerment: a pilot study" (Percepciones de la 
enfermedad en pacientes de hemodialisis (HO, por sus siglas en ingles) con 
diabetes mellitus (OM) del tipo 2 y su asociacion con la potenciacion: un estudio 
piloto). EI proyecto terminara con mi disertacion. 
Le pido que lea las siguientes paginas de esta Carta de Solicitacion que explican 
en mayor detalle el estudio, la duracion esperada de su participacion, la 
descripcion de los procedimientos (incluyendo nombre y contenidos especificos 
de todas las encuestas), la declaracion de la naturaleza voluntaria de su 
participacion, la declaracion sobre como se preservara el anonimato y la manera 
en que su informacion sera almacenada de manera segura para mantener la 
confidencialidad. 
Por medio de la presente 10 invito a participar en este estudio de investigacion 
debido a que usted es un paciente con diabetes mellitus del tipo 2. 
Le pido que comience respondiendo las siguientes preguntas: marque con un 
circulo sus respuestas. 
4. 	 ~Tiene entre 18 y 85 arios de edad? 

Si No 

5. 	 ~Sufre de diabetes mellitus del tipo 2? 

Si No 

6. 	 ~NO tiene antecedentes de terapia de reemplazo renal? 

Si No 

Si respondio 51 a TODA5 las preguntas anteriores, usted CALIFICA para 
participar en este estudio, abra el paquete de investigacion y comience a 
responder los cuestionarios que se adjuntan. Coloque el cuestionario con las 
respuestas en el sobre que se adjunta. Cierre el sobre y coloquelo en el buzon 
designado de la unidad. 
Si usted respondio NO a ALGUNA de las preguntas anteriores, NO CALIFICA 
para participar en este estudio. Muchas gracias por su tiempo y Ie pedimos que 
devuelva el paquete de investigacion depositflndolo en el buzon designado de su 
unidad. 
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Appendix B 
Informed Consent 
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Informed Consent 
Research title: 
Illness perceptions of hemodialysis (HD) patients with Type 2 diabetes mellitus 
(DM) and their association with empowerment: a pilot study 
Researchers' affiliation: 
Any interested patient is invited to participate in a research study that will 
explore illness perceptions of patients with Type 2 DM (either undergoing HD 
treatment or non-dialysis patients with Type 2 DM), and their association with 
empowerment. 
This study is being undertaken at Seton Hall University (SHU) located in 
South Orange, New Jersey in the Department of Graduate Programs in Health 
Sciences located on campus at Alfieri Hall. The primary investigator (PI) of this 
study is Jaime L Pula, MS, RD, whom is a doctoral candidate in the Ph.D. 
program for Health Sciences, Leadership Track. The PI's Committee Chair is 
Vincent A. DeBari, Ph.D., Professor of Medicine. The PI has followed all policies 
and procedures related to this study as set forth by the SHU's Institutional 
Review Board (IRB). 
Purposes of the study: 
The purposes of this descriptive (exploratory) study are: 1) to investigate the 
illness perceptions of HD patients with Type 2 DM; and 2) to examine if there is 
an association between these illness perceptions and perceptions of 
empowerment. 
Duration of the participant's involvement in the study: 
The administrative personnel will make all interested participants aware that 
this study will include a one-time collection of data materials {Brief Illness 
Perceptions Questionnaire or Brief IPQ (Appendix C), Diabetes Empowerment 
Scale - Short Form or DES-SF (Appendix D), and General Information Form or 
GIF (Appendix E)} that will take approximately 45 minutes. 
Explanation of procedures: 
All participants will continue usual nursing care during their regularly 
scheduled HD treatment at SJRMC, which is located at 703 Main Street in 
Paterson, NJ (northeastern NJ) (Chief Nephrologist: Chandra B. Chandran, MD) 
or family medicine clinic visit. 
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Potential participants (HD patients with Type 2 OM or non-dialysis patients 
with Type 2 OM) will be identified by designated administrative personnel of the 
institution. These participants will be HD patients with Type 2 OM or non-dialysis 
patients with Type 2 OM of the participating institution. They will be recruited 
through a solicitation letter (Appendix A). This letter will include an explanation of 
the purpose of the research study, an indication that participation is voluntary, 
and that confidentiality and participant anonymity will be maintained throughout 
the study. This letter will be stapled on the research packet. The packet will 
contain the survey questionnaire and a return envelope. The packet will be given 
to each patient during their normally scheduled HD treatment or family medicine 
clinic visit by administrative personnel. Eligibility will be determined by the 
completion of 3 questions in the solicitation letter (Appendix A): 1) Are you 
between the ages of 18 and 85?; 2) Do you have Type 2 Diabetes Mellitus?; and 
3) Do you have NO history of renal replacement therapy? If the participants 
meet the eligibility criteria they will be requested to complete the Brief IPQ 
(Appendix B) (Broadbent, et. aI., 2005) (to collect illness perceptions data), the 
DES-SF (Appendix C) (Anderson, et. aI., 2000; Tsay & Hung, 2004) (to collect 
empowerment data). and the GIF (Appendix D) (to collect sociodemographic 
information data). The collection of all data will be a one-time collection that will 
take approximately 45 minutes. English and Spanish versions of all tools will be 
provided in the research packet. Any questions the participants may have will be 
encouraged and promptly answered by the administrative personnel. Please 
note participants will be able to stop offering their illness perceptions and 
empowerment responses at any time, without any questions or negative 
responses from the administrative personnel. All participants will be asked to 
seal the completed questionnaire in the return envelope, and place the envelope 
in a designated drop box located on the out-patient HD unit. The primary 
investigator (PI) will collect the boxes within two (2) weeks after distribution. 
Any participant will complete these questionnaires during his or her HD 
treatment session or family medicine clinic visit. The time required to complete 
the questionnaires should be no longer than 45 minutes. Upon completion, he or 
she will return the completed questionnaires in a sealed envelope (enclosed) and 
place in a designated drop box located on the out-patient HD unit or family 
medicine clinic. Any participant will keep the solicitation letter, which has been 
provided inside the research packet, so as to ensure anonymity. Any participant 
will return the questionnaires to the designated drop box within 2 weeks of 
receipt. 
Surveys. If the participants meet the eligibility criteria they will be requested 
to complete the Brief IPQ (Appendix B) (Broadbent. et. aI., 2005) (to collect 
illness perceptions data), the DES-SF (Appendix C) (Anderson, et. aI., 2000; 
Tsay & Hung, 2004) (to collect empowerment data), and the GIF (Appendix D) 
(to collect sociodemographic information data). The collection of all data will be a 
one-time collection that will take approximately 45 minutes. {Sample questions 
any participant is asked to answer include (but, are not limited to) what his or her 
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ethnicity is, his or her age, whether "(he or she) believe(s) (he or she) know(s) 

the positive ways (he or she) cope(s) with diabetes-related stress", and "how 

much does (his or her) illness affect (his or her) life?} 

Voluntary nature: 

The return of the completed questionnaires will be considered consent from 
any study participant (HD patient with Type 2 DM or non-dialysis patient with 
Type 2 DM). Any participant understands he or she is able to stop offering his or 
her responses to any of the questionnaires at any time, without any questions or 
negative responses from the administrative personnel. 
Anonymity: 
Anonymity is preserved. Participant names are not associated with any of the 
collected data. You will not be identified by name or description in any reports or 
publications about this study. Any participant does not authorize his or her name 
to be associated with any of the collected data; therefore, he or she is assured all 
records remain anonymous and confidential. 
Confidentia lity: 
Any participant is assured any information obtained in connection with this 
study is held in strict confidence and kept securely by the PI. All information in 
this study will be kept strictly confidential. Data will be entered into the SPSS 
statistical package (Version 17.0) and maintained on a USB memory drive. All 
research data will be stored in a locked file cabinet drawer on the out-patient HD 
unit at St. Joseph's Regional Medical center. The PI and the three (3) members 
of her dissertation committee are the only individuals who will have access to all 
of the research data for a period of three (3) years. Thereafter, all research data 
will be destroyed via professional shredding services. 
If a participant is excluded from the study for any reason, his or her materials 
are discarded via professional shredding services. No video or audio tapes are 
involved in the study. Information will be available at the end of the study, if 
anyone is interested. 
Contact information: 
If any participant has any problems, questions or concerns, he or she does 
not hesitate to contact the PI, Jaime L. Pula, MS, RD, Primary Investigator, 
doctoral candidate, in the Department of Graduate Programs in Health Sciences 
at SHU, at (888) 728-7778. Any participant may contact the PI, the PI's 
Committee Chair, Vincent A. DeBari, Ph.D., at (973) 877-2813 or Dr. Mary F. 
Ruzicka, Director of the SHU IRB, at (973) 313-6314 or Dr. Patrick Perin, 
Chairman of SJRMC IRB, at (973) 754-2768 directly for answers to pertinent 
questions about the research and his or her rights, if necessary. 
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Consentimiento informado 
Titulo de la investigacion: 
Illness perceptions of hemodialysis (HD) patients with Type 2 diabetes mellitus 
(DM) and their association with empowerment: a pilot study' (Percepciones de la 
enfermedad en pacientes de hemodialisis (HD, p~r sus siglas en ingles) con 
diabetes mellitus (DM) del tipo 2 y su asociacion con la potenciacion: un estudio 
piloto) 
Afiliacion del investigador: 
Se invita a todo paciente interesado a participar en un estudio de 
investigacion que explorara las percepciones de la enfermedad de los pacientes 
con DM del tipo 2 (bajo tratamiento de HD 0 pacientes sin dialisis con DM del 
tipo 2) y su asociacion con la potenciacion. 
Este estudio se lIeva a cabo en la Universidad Seton Hall (SHU, p~r sus 
siglas en ingles), ubicada en South Orange, Nueva Jersey, en el Departamento 
de Programas de Graduados en Ciencias de la Salud, ubicado en el campus de 
Alfieri Hall. EI investigador principal de este estudio es Jaime L. Pula, MS, RD, 
candidato a doctorado en el programa de Doctorado de Ciencias de la Salud, 
Leadership Track. EI Presidente del Comite del Investigador Principal es Vincent 
A. DeBari, Ph.D., Profesor de Medicina. Ellnvestigador Principal ha cumplido 
con todas las polfticas y procedimientos relacionados con este estudio, tal como 
10 establece el Consejo de Revision Institucional (IRB, p~r sus siglas en ingles) 
de la SHU. 
Objetivos del estudio: 
Los objetivos de este estudio descriptiv~ (exploratorio) son: 1) investigar las 
percepciones de la enfermedad de los pacientes de HD con DM del tipo 2; y 2) 
examinar la asociacion entre dichas percepciones de la enfermedad y la 
potenciacion. 
Duracion de la participacion de los participantes en el estudio: 
EI personal administrativo comunicara a todos los participantes interesados 
que este estudio incluira una recopilacion p~r (mica vez de materiales de datos 
{Cuestionario Breve de Percepciones de la Enfermedad 0 IPO (por sus siglas en 
ingles) Breve (Anexo C), Escala de Potenciacion de Diabetes - Version 
Resumida 0 DES-SF, p~r sus siglas en ingles (Anexo D) y Formulario de 
Informacion General 0 GIF, p~r sus siglas en ingles (Anexo E)} que lIevara 
aproximadamente 45 minutos. 
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Explicacion de los procedimientos: 
T odos los participantes continuaran con sus cuidados de enfermeria 
normales durante su tratamiento de HD programado normalmente en SJRMC, 
ubicado en 703 Main Street en Paterson, NJ (noreste de NJ) (Jefe de Nefrologia: 
Chandra B. Chandran, MD) 0 visita a la cHnica de medicina familiar. 
EI personal administrativ~ designado de la institucion identificara a los 
participantes potenciales (pacientes de HD con DM del tipo 2 0 pacientes sin 
dialisis con DM del tipo 2). Dichos participantes seran pacientes de HD con DM 
del tipo 2 0 pacientes sin dialisis con DM del tipo 2 de la institucion participante. 
Seran reclutados a traves de una carta de solicitacion (Anexo A). Dicha carta 
incluira una explicacion del objetivo del estudio de investigacion, una indicacion 
de que la participacion es voluntaria y que se mantendra la confidencialidad y 
anonimato de los participantes durante el estudio. Dicha carta sera abrochada al 
paquete de investigacion. EI paquete incluira el cuestionario de la encuesta y un 
sobre de respuesta. EI personal administrativ~ entregara un paquete a cada 
paciente durante su tratamiento de HD normalmente programado 0 visita a la 
clinica de medicina familiar. La elegibilidad sera determinada a traves de las 
respuestas a las tres preguntas en la carta de solicitacion (Anexo A): 1) (.,Tiene 
entre 18 y 85 anos de edad?; 2) Sufre de diabetes mellitus del tipo 2; y 3) (.,NO 
tiene antecedentes de terapia de reemplazo renal? Si los participantes cumplen 
con los criterios de elegibilidad, se les pedira que respondan el IPO Breve 
(Anexo B) (Broadbent, et. aI., 2005) (para recopilar datos de percepcion de la 
enfermedad), la DES-SF (Anexo C) (Anderson, et. aI., 2000; Tsay & Hung, 2004) 
(para recopilar datos de potenciacion) y el GIF (Anexo D) (para recopilar datos 
de informacion sociodemografica). La recopilacion de datos sera por (mica vez y 
tomara aproximadamente 45 minutos. Se proporcionaran versiones en ingles y 
espanol de todas las herramientas en el paquete de investigaciOn. Se alentara a 
los participantes a formular toda pregunta que puedan tener y las mismas seran 
respondidas a la brevedad por el personal administrativo. Tenga en cuenta que 
los participantes pod ran dejar de brindar sus respuestas sobre percepciones de 
la enfermedad y potenciacion en cualquier momento, sin ninguna pregunta 0 
respuestas negativas por parte del personal administrativo. Se les pedira a todos 
los participantes que pongan el cuestionario con las respuestas en el sobre de 
respuesta y que 10 coloquen en el buzon designado ubicado en la unidad de HD 
de pacientes externos. EI investigador primario recogera los buzones dentro de 
dos (2) semanas despues de la distribucion. 
Todos los participantes responderan a los cuestionarios durante sus sesiones 
de tratamiento de HD 0 visitas a la clfnica de medicina familiar. EI tiempo 
necesario para responder los cuestionarios no debe ria ser de mas de 45 
minutos. Despues de responderlos, los participantes pondran los cuestionarios 
con las respuestas en un sobre cerrado (que se adjunta) y 10 colocaran en un 
buzon designado ubicado en la unidad de HD de pacientes externos 0 de la 
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clfnica de medicina familiar. Todos los participantes conservaran la carta de 
solicitacion, que fue incluida dentro del paquete de investigacion, de manera de 
garantizar el anonimato. Todos los participantes colocaran los cuestionarios en 
el buzon designado dentro de las 2 semanas a partir de la recepcion. 
Encuestas. Si los participantes cumplen con los criterios de elegibilidad, se 
les pedira que respondan ellPQ Breve (Anexo B) (Broadbent, et. aI., 2005) (para 
recopilar datos de percepcion de la enfermedad), la DES-SF (Anexo C) 
(Anderson, et. aI., 2000; Tsay & Hung, 2004) (para recopilar datos de 
potenciacion) y el GIF (Anexo D) (para recopilar datos de informacion 
sociodemografica). La recopilacion de datos sera por (mica vez y tomara 
aproximadamente 45 minutos. {Entre las preguntas que se Ie pedira que 
respondan a todos los participantes podemos mencionar (de forma enunciativa y 
no limitativa) cual es su origen etnico, su edad, si consideran que conoce 
maneras positivas para hacer frente al estres relacionado con la diabetes y en 
que media la enfermedad afecta a su vida.} 
Naturaleza voluntaria: 
EI envio de los cuestionarios con las respuestas sera considerado como 
consentimiento para la paliicipacion en el estudio (paciente de HD con DM del 
tipo 2 0 paciente sin dialisis con DM del tipo 2). Todos los pacientes comprenden 
que pueden dejar de proporcionar sus respuestas a cua/quiera de los 
cuestionarios en cua/quier momenta sin ninguna pregunta 0 respuesta negativa 
por parte del personal administrativo. 
Anonimato: 
Se preservara el anonimato. Los nombres de los participantes no esttm 
asociados a ninguno de los datos recopilados. Usted no sera identificado por 
nornbre 0 descripcion en ningun informe 0 publicacion sobre este estudio. Los 
participantes no autorizan a que su nombre quede asociado a ninguno de los 
datos recopilados; por 10 tanto, se garantiza a los mismos que sus legajos 
permaneceran anonimos y confidenciales. 
Confidencialidad: 
Se garantiza a todos los participantes que el investigador principal mantendra 
a toda la informacion obtenida en relacion con este estudio en estricta 
confidencialidad y seguridad. Toda la informacion en este estudio sera 
conservada en estricta confidencialidad. Los datos seran ingresados en un 
paquete estadistico SPSS (version 17.0) y conservados en una unidad de 
memoria USB. Todos los datos de investigacion seran almacenados en un cajon 
de armario de archivos con lIave en la unidad de HD de pacientes externos del 
Centro Medico Regional St. Joseph. EI investigador principal y los tres (3) 
miembros de su comite de disertacion son las unicas personas que tendran 
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acceso a todos los datos de investigacion durante un periodo de tres (3) arios. A 
partir de ese momento, todos los datos de investigacion seran destruidos por 
medio de servicios de destruccion de documentos profesionales. 
Si un participante es excluido del estudio por cualquier motiv~, sus materiales 
seran descartados por medio de servicios de destruccion de documentos 
profesionales. EI estudio no hace uso de cintas de video ni de audio. La 
informacion estara disponible al final del estudio, si alguien esta interesado. 
Informacion de contacto: 
Si un participante tiene algun problema, pregunta 0 duda, no debe dudar en 
comunicarse con el investigador principal Jaime L. Pula, MS, RD, Investigador 
Principal, candidato a doctorado en el Departamento de Programas de 
Graduados en Ciencias de la Salud de la SHU, al telefono (888) 728-7778. 
Todos los participantes pueden comunicarse con el investigador principal, el 
Presidente del Comite del investigador principal, Vincent A. DeBari, Ph.D., al 
telefono (973) 877-2813, con el Dr. Mary F. Ruzicka, Director de SHU IRB, al 
telefono (973) 313-6314 0 con el Dr. Patrick Perin, Presidente de SJRMC IRB, al 
telefono (973) 754-2768 directamente para obtener respuestas a preguntas 
pertinentes sobre la investigacion y sus derechos, si es necesario. 
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Appendix C 
Brief Illness Perception Questionnaire (Brief-IPQ) 
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Brief Illness Perception Questionnaire (Brief-IPQ) 
For the following questions, please circle the number that best corresponds to 
your views: 
How much does your illness affect your life? 
o 1 2 3 4 5 6 7 8 
no affect 
at all 
How long do you think your illness will continue? 
o 1 2 3 4 5 6 7 8 
a very 
short time 
How much control do you feel you have over your illness? 
o 1 2 3 4 5 6 7 8 
absolutely 
no control 
How much do you think your treatment can help your illness? 
o 1 2 3 4 5 6 7 8 
not at all 
How much do you experience symptoms from your illness? 
o 1 2 3 4 5 6 7 8 
no symptoms 
at all 
How concerned are you about your illness? 
o 1 2 3 4 5 6 7 8 
not at all 
concerned 
How well do you feel you understand your illness? 
o 1 2 3 4 5 6 7 8 
don't understand 
at all 
9 10 
severely 
affects my 
life 
9 10 
forever 
9 10 
extreme 
amount 
of control 
9 10 
extremely 
helpful 
9 10 
many severe 
symptoms 
9 10 
extremely 
concerned 
9 10 
understand 
very clearly 
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How much does your illness affect you emotionally? (e.g. does it make you 
angry, scared, upset or depressed? 
o 1 2 3 4 5 6 7 8 9 10 
not at all extremely 
affected affected 
emotionally emotionally 
Please list in rank-order the three most important factors that you believe 
caused your illness. 
The most important causes for me: 
1. ___________________________________________________________ 
2. ____________________________________________ 
3. __________________________________ 
Broadbent, et. aI., 2006 
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EI Cuestionario Breve de Percepcion de Enfermedad 
En las siguientes preguntas, por favor, marque con un circulo el numero 
que mejor 
representa su opinion 
i.Cuanto afecta su enfermedad a su vida? 
o 1 2 3 4 5 6 7 8 9 10 
no la afecta absolutamente nada afecta gravemente 
mi vida 
i.Cuanto cree Ud. que durara su enfermedad? 
o 1 2 3 4 5 6 7 8 9 10 
muy poco tiempo para siempre 
l.Cuanto control siente Ud. que tiene sobre su enfermedad 
o 1 2 3 4 5 6 7 8 9 10 
absolutamente ninguno control total 
i.En que medida cree Ud. que su tratamiento ayuda a mejorar su 
enfermedad? 
o 1 2 3 4 5 6 7 8 9 10 
absolutamente nada ayuda muchisimo 
i.En que medida siente Ud. sintomas debidos a su enfermedad? 
o 1 2 3 4 5 6 7 8 9 10 
absolutamente ningun sintoma muchos sintomas 
graves 
i.En que medida esta Ud. preocupado por su enfermedad? 
o 1 2 3 4 5 6 7 8 9 10 
absolutamente nada de preocupado extremadamente 
preocupado 
l.En que medida siente Ud. que entiende su enfermedad? 
o 1 2 3 4 5 6 7 8 9 10 
no la entiendo nada la entiendo muy 
claramente 
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10 
l,En que medida 10 afecta emocionalmente su enfermedad? (Es decir, l,Lo 
hace sentirse con 
rabia, asustado, enojado 0 deprimido?) 
o 1 2 3 4 5 6 7 8 9 
Absolutamente nada de afectado emocionalmente 
Extremadamente afectado 
emocionalmente 
Por favor, haga una lista con los tres factores mas importantes que Ud. 
cree que causaron su enfermedad, enumerelos en orden de importancia. 
Las tres causas que yo considero mas importantes son: 
1. ______________________________ 
2. ____________________________ 
3. _______________________________ 
Broadbent, et. aI., 2006 
- 153 ­
Appendix C 
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Diabetes Empowerment Scale - Short Form (DES-SF) 
The 8 items below constitute the DES-SF. The scale is scored by averaging the 
scores of all completed items (Strongly Disagree =1, Strongly Agree = 5) 
Check the box that gives the best answer for you. 
1. 	 In general, I believe that I OJ 02 03 04 05 
know what parte s) of taking Strongly Somewhat Neutral Somewhat Strongly 
care of my diabetes that I Disagree Disagree Agree Agree 
am dissatisfied with. 
2. In general, I believe that I am 01 02 03 04 05 
able to tum my diabetes Strongly Somewhat Neutral Somewhat Strongly 
goals into a workable plan. Disagree Disagree Agree Agree 
3. 	 In general, I believe that I 01 02 03 04 05 
can try out different ways of Strongly Somewhat Neutral Somewhat Strongly 
overcoming barriers to my Disagree Disagree Agree Agree 
diabetes goals. 
4. 	 In general, I believe that I OJ 02 03 04 05 
can find ways to feel better Strongly Somewhat Neutral Somewhat Strongly 
about having diabetes. Disagree Disagree Agree Agree 
DES-SF; Diabetes Research and Training Center 

© University of Michigan, 2003 

Anderson, et. aI., 2000 
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Diabetes Empowerment Scale-Short Form (DES-SF) 

Version en espanol. 

Muy De Ni En desa Muyen 
de acuerdo de acuerdo cuerdo desacuerdo 
acuerdo nien 
desacuerdo 
1. En general creo que yo conozco con que 
partes del cuidado de mi diabetes estoy 
insatisfecha(o). 
2. En general creo que yo soy capaz de convertir 
mis metas en un plan de acci6n practico y 
concreto. 
3. En general creo que yo puedo intentar hacer 
diferentes cosas para superar las barreras 
enfrento para lograr mis metas. 
4. En general creo que yo puedo decir como me 
estoy sintiendo viviendo con la diabetes. 
5. En general creo que yo conozco maneras 
positivas que uso para enfrentar el estres que 
me causa la diabetes. 
6. En general creo que yo conozco en donde 
puedo encontrar apoyo para vivir y cuidar de 
mi diabetes. 
7. En general creo que yo conozco 10 que me 
ayuda a permanecer motivado para cuidar de 
mi diabetes. 
8. En general creo que yo me conozco 10 
suficiente como persona como para tomar las 
decisiones que me convienen para el cuidado 
de mi diabetes. 
Muchas Gracias por reponder el cuestionario. 
Anderson, et. aI., 2000 
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General Information Form (GIF) 
Please mark answers by circling the most appropriate choice unless otherwise 
indicated to answer by writing in most accurate information. Thank you for your 
participating in this questionnaire. 
SOCIODEMOGRAPHIC 
1) I am: 
Male 
Female 
2) My age is (in years): 
If you do not receive hemodialysis treatments at all, please skip to 
Question #4. 
3) I have been on hemodialysis for a total length of time of (in months): ___ 
4) Languages I speak at home or with my family and/or friends include: 
English 
Spanish 
Arabic 
Bengali 
Turkish 
Other: ______________ 
5) My ethnicity or race is: 
Black 
White 
Hispanic 
Native American 
Asian 
Pacific Islander 
Middle Eastern 
Other: ______________ 
6) The most years of schooling in basic education I received is: 
6 years schooling 
9 years schooling 
12 years schooling 
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7) The type of vocational educations I received is: 
No education 
Secondary/upper secondary level 
Polytechnic/college or univerSity 
8) My current employment status is: 
Employment or student 
Retired 
Unemployed 
Sick leave 
9) I have Type 2 Diabetes Mellitus. 
Yes 
No 
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Formulario de informacion general 
Por favor elije la repuesta mas apropiada con un circulo si no indican contestar 
con escribir con la mas exacta informaci6n. Gracias por participar en este 
cuestionario. 
SOCIODEMOGRAFICAS 
1} Sexo: 
Masculino 
Femenino 
2) Edad (en anos): 
Si nunca has recibido tratamientos por hemodialisis, por favor siga a la 
pregunta #4. 
3) Estoy recibiendo tratamientos por hemodialisis para __ meses. 
4) Idiomas que hablo en casa 0 con mi familia y amigos son: 
Ingles 
Espanol 
Arabe 
Bengali 
Turco 
Otro: ______________ 
5) Mi origen atnico es: 
Negro 
Blanco 
Hispano 
Nativo Americano 
Asiatico 
De las Islas del Pacifico 
De Oriente Medio 
Otro: 
6) Maximo numero de alios en educaci6n basica: 
6 alios 
9 alios 
12 alios 
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7) EI tipo de profesional educaci6n que e recibido es: 
Ninguna educaci6n profesional 
Universidad secundaria 
Politecnico/Universidad 
8) Mi actual status de empleo es: 
Empleado 0 estudiante 
Retirado 
Desempleado 
Baja por enfermedad 
9) Tengo tipo 2 Diabetes Mellitas. 
Si 
No 
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Completion Certificate of Human Participant Protection 
Cottific.ate of Completion 
The Nationallnstltutcs of Hoal'lh (NIH) 011109 0' Extramural Research 
Cer1ifIeB thai Jaime Pula successfully eompleled tho NIH VoIob-basGd 
training OOUffKl 'Plu1ll<;Iing HlJrT1I'IIl RflletII'tlh l".!Irtidpents". 
Cer1ifll:a'ioo Number: 443544 
http://pbrpJlihtraining.oom.~1I!CI.'tl.php?c· 442544 5.1812010 
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~1oseph's 
Regional Medical Center 703 Main Street 
Paterson, New Jersey 07503 
973.754.2000 
INSTITUTIONAL REVIEW BOARD 

(973) 754*2768 FAX (973) 7544355 

EXPEDITED REVIEW REVISION - 2010 

May 26,2010 
Jaime L. Pula, MS, RD, 

St. Joseph's Regional Medical Center 

703 Main Street 

Paterson, NJ 07503 

Dear Ms. Pula: 
PR# 09~35 "Illness Perceptions Of Hemodialysis (lID) Patients With Type 2 Diabetes Mellitus 
(DM) And Their Association With Empowerment: APilot Study," Revisions includes the 
addition ofMichael D. DeLisi, MD as a co-investigator; Solicitation Letter (Appendix A) to the 
informed consent; minor aesthetic changes to the instruments (Appendix B; Appendix C) revised 
(Appendix D) method ofcoding was approved through expedited revision review by Dr. Patrick 
Perin on May 26, 2010. 
I have reviewed the aforementioned revision of PR #09-035: Since the revisions do not present 
any added risk, I have approved this revision through expedited review, 45 CFR 46,21 CFR 50, 
56. 
My best wishes for your efforts in the proposed area of research you are conducting 
continue to be fruitful and rewarding. 
Yours very truly, 
Patrick V. Perin, MD 

Chairman, Institutional Review Board 

PVPl1h 
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Appendix H 

Permission to Use the Brief IPQ 

--- On Mon, 12/7/09, Jaime Pula <mvprdllc.@yahoo.com> wrote: 

From: Jaime Pula <mvprdllc@yahoo.com> 

Subject: Re: Approval to Use Brief IPQ 

To: "Elizabeth Broadbent" <lizbroadbent@c1ear.net.nz> 

Date: Monday, December 7,2009,2:46 PM 

Thank you for your kind consideration. I will be sure to forward my findings to you. 

Happy Holidays! 

--- On Sun, 12/6/09, Elizabeth Broadbent <lizbroadbent@clear.net.nz> wrote: 
From: Elizabeth Broadbent <lizbroadbent@c1ear.net.nz> 

Subject: Re: Approval to Use Brief IPQ 

To: "Jaime Pula" <mvprdllc@yahoo.com> 

Date: Sunday, December 6, 2009, 1 :43 AM 

Dear Jaime 

Yes you may 

kind regards 

Liz 

On 6/12/2009, at 2:04 PM, Jaime Pula wrote: 

Dear Ms. Broadbent, 

My name is Jaime L. Pula. I am a doctoral candidate at Seton Hall University located in 

South Orange, NJ. I am seeking your approval to use the Brief IPQ to collect data on 

illness perceptions in hemodialysis patients with Type 2 DM as my dissertation topic in 

partial fulfillment of a Ph.D. in Health Sciences. 

Please let me know what steps I need to take to obtain your permission. 

Sincerely Yours, 

Jaime L. Pula, MS, RD 

Doctoral Candidate 

Seton Hall University 

(732) 207-8819 
MVPRDLLC@yahoo.com 
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Certification of Spanish Translation 
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~STA-USA~ 

ASTA-USA Translation S4!nices. Inc. 

PostOffice 8all25. Main SIn!et I H3rtviIIe. Wyoming 82215 USA 

T@L: 866.446.1880 I Fax.: II66..2lJ7.fJ6061_.astHEa.cam '_.I..egilIITI3I'ISIatiDnSaluticns.CDIIl 

CERTIFIED TRANSLATION 
IFIRST NAME: Jai_ IMmDlE NAME: 
I DIVISION: MIACOMPANY: MIA 
T-vet Unguages: 
HARTVJllE, WYOMJNG 
WITH REFERENCE TO THE ABOVE MENTIONED MATERIALSJDOCUMENTS. we .. ASTA-USA Translaon 
Services, Inc•• a professional document translation company. aUItst that 'I.M language translltion complMlld by 
ASTA-USA's certified professional translators. ~ 10 'I.M best of our judgment. an accurate ,lind correct 
inlIIrprNtion of 1M terminolClgylcontMt of 1M source document{s}.. This Is to 0itI'tifr thIt ~ of thIt 
t.r.In5Iation only. We do not guam"," that the original is a genu~e document or that 'I.M statements contained 
in thtoriginal documen1(s}.. tn.Kt. 
IN WITNESS WHEREOF. ASTA-USA Tramlation Services, 1ncorpor,Nd h.1s cauHd the Certifieat. to be 
signed by its duly authorized orfioer(s). 
By: ~,..__ .___.• D_: t-4June2010 
Alain J Roy, PrHident 
A copy of the translat.-d version is at:tac:hed to this statement of CIH'tification. 
~N"lfiDMlAsHriliin. ... 
JUitiuy mmplI!I!!I5a. TramJatlln 
AS'TA.uSAT~ SerwicI!s. ~ -Member!lJ7031 
A lIMtI».rin Good  
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